Need help?

800-5315-2751 Hours: 8am-5pm PST M-Th;  8am-4pm PST Fri
Medicine Lakex
medicinelakex1.com
/w/wbpf.us1.html

Dans la pharmacie en ligne Viagra-représenté Paris large éventail de la dysfonction érectile anti-plus consommée. Générique Levitra (vardenafil), Cialis (tadalafil) et achat viagra pour homme, dont le prix est acceptable pour tous les budgets.1

Yo no soy un gran amante de pedir medicamentos por internet. Pero a veces la necesidad de herramientas, que en las farmacias regulares o no, o rara vez viagra comprar Recibes como un paquete, todo montado y embalado.

Microsoft word - wbpf anti-doping rules

World Bodybuilding & Physique Sports Federation Anti-Doping Rules WBPF Anti-Doping Rules 2009
August 2009

TABLE OF CONTENTS
 Fundamental
for
the
Code
and
IF's
3
 Scope
4
ARTICLE 1
DEFINITION OF DOPING . 5
ARTICLE 2
ANTI-DOPING RULE VIOLATIONS. 6
ARTICLE 3
PROOF OF DOPING . 9
ARTICLE 4
THE PROHIBITED LIST . 11
ARTICLE 5
TESTING . 14
ARTICLE 6
ANALYSIS OF SAMPLES. 19
ARTICLE 7
RESULTS MANAGEMENT . 20
ARTICLE 8
RIGHT TO A FAIR HEARING . 26
ARTICLE 9
AUTOMATIC DISQUALIFICATION OF INDIVIDUAL RESULTS
. 28

ARTICLE 10
SANCTIONS ON INDIVIDUALS . 28
ARTICLE 11
CONSEQUENCES TO TEAMS . 38
ARTICLE 12
SANCTIONS AND COSTS ASSESSED AGAINST NATIONAL
FEDERATION
S . 38
ARTICLE 13
APPEALS . 40
ARTICLE 14
REPORTING AND RECOGNITION . 44
ARTICLE 15
MUTUAL RECOGNITION . 47
ARTICLE 16
INCORPORATION OF IF ANTI-DOPING RULES . 47
ARTICLE 17
STATUTE OF LIMITATION . 47
WBPF Anti-Doping Rules
August 2009

ARTICLE 18
WBPF COMPLIANCE REPORTS TO WADA . 47

ARTICLE 19

AMENDMENTS AND INTERPRETATION OF ANTI-DOPING
RULES….…47


ARTICLE 20

ADDITIONAL ROLES AND RESPONSABILITIES OF ATHLETES
AND OTHER PERSONS
……………………………………………………………. 49


APPENDIX 1

DEFINITIONS

APPENDIX 2

WBPF Anti-Doping Rules
August 2009

At the Executive Officers Meeting held on 13th August 2009 in Pattaya City, Thailand, WBPF accepted the revised (2009) World Anti-Doping Code (the "Code"). These Anti-Doping Rules are adopted and implemented in conformance with WBPF's responsibilities under the Code, and are in furtherance of WBPF's continuing efforts to eradicate doping in the sport of bodybuilding, fitness physique, athletic physique and model physique. Anti-Doping Rules, like Competition rules, are sport rules governing the conditions under which sport is played. Athletes and other Persons accept these rules as a condition of participation and shall be bound by them. These sport-specific rules and procedures, aimed at enforcing anti-doping principles in a global and harmonized manner, are distinct in nature and, therefore, not intended to be subject to, or limited by any national requirements and legal standards applicable to criminal proceedings or employment matters. When reviewing the facts and the law of a given case, all courts, arbitral tribunals and other adjudicating bodies should be aware of and respect the distinct nature of the anti-doping rules in the Code and the fact that these rules represent the consensus of a broad spectrum of stakeholders around the world with an interest in fair sport. Fundamental Rationale for the Code and IF's Anti-Doping Rules
Anti-doping programs seek to preserve what is intrinsically valuable about sport. This intrinsic value is often referred to as "the spirit of sport"; it is the essence of Olympism; it is how we play true. The spirit of sport is the celebration of the human spirit, body and mind, and is characterized by the following values: • Ethics, fair play and honesty • Health • Excellence in performance • Character and education • Fun and joy • Teamwork • Dedication and commitment • Respect for rules and laws • Respect for self and other participants • Courage • Community and solidarity Doping is fundamentally contrary to the spirit of sport. WBPF Anti-Doping Rules
August 2009

These Anti-Doping Rules shall apply to WBPF, each National Federation of IF, and each Participant in the activities of IF or any of its National Federations by virtue of the Participant's membership, accreditation, or participation in WBPF, its National Federations, or their activities or Events. To be eligible for participation in WBPF events, a competitor must be a member of a club/organization affiliated to his or her National Federation. The WBPF will only recognize competitors who have personally signed the Appendix 2 consent form, in the actual form approved by the WBPF Executive Council. All forms from under-age applicants must be counter-signed by their legal guardians. The National Federation must guarantee that all athletes accept the Rules of the WBPF, including these WBPF Anti-Doping Rules. It is the responsibility of each National Federation to ensure that all national-level Testing on the National Federation's Athletes complies with these Anti-Doping Rules. In some countries, the National Federation itself will be conducting the Doping Control described in these Anti-Doping Rules. In other countries, many of the Doping Control responsibilities of the National Federation have been delegated or assigned by statute or agreement to a National Anti-Doping Organization. In those countries, references in these Anti-Doping Rules to the National Federation shall apply, as appropriate, to the National Anti-Doping Organization. These Anti-Doping Rules shall apply to all Doping Controls over which WBPF and its National Federations have jurisdiction. WBPF Anti-Doping Rules
August 2009

ARTICLE 1 DEFINITION OF DOPING
Doping is defined as the occurrence of one or more of the anti-doping rule violations set forth in Article 2.1 through Article 2.8 of these Anti-Doping Rules. ARTICLE 2 ANTI-DOPING RULE VIOLATIONS
Athletes and other Persons shall be responsible for knowing what constitutes an anti-doping rule violation and the substances and methods which have been included on the Prohibited List. The following constitute anti-doping rule violations: [Comment to Article 2: The purpose of Article 2 is to specify the circumstances and conduct which constitute violations of anti-doping rules. Hearings in doping cases will proceed based on the assertion that one or more of these specific rules has been violated.] 2.1 The presence of a Prohibited Substance or its Metabolites or Markers in an Athlete's It is each Athlete's personal duty to ensure that no Prohibited Substance enters his or her body. Athletes are responsible for any Prohibited Substance or its Metabolites or Markers found to be present in their Samples. Accordingly, it is not necessary that intent, fault, negligence or knowing Use on the Athlete's part be demonstrated in order to establish an anti-doping violation under Article 2.1. [Comment to Article 2.1.1: For purposes of anti-doping violations involving the presence of a Prohibited Substance (or its Metabolites or Markers), these Anti-Doping Rules adopt the rule of strict liability which was found in the Olympic Movement Anti-Doping Code ("OMADC") and the vast majority of pre-Code anti-doping rules. Under the strict liability principle, an Athlete is responsible, and an anti-doping rule violation occurs, whenever a Prohibited Substance is found in an Athlete's Sample. The violation occurs whether or not the Athlete intentionally or unintentionally used a Prohibited Substance or was negligent or otherwise at fault. If the positive Sample came from an In-Competition test, then the results of that Competition are automatically invalidated (Article 9 (Automatic Disqualification of Individual Results)). However, the Athlete then has the possibility to avoid or reduce sanctions if the Athlete can demonstrate that he or she was not at fault or significant fault (Article 10.5 (Elimination or Reduction of Period of Ineligibility Based on Exceptional Circumstances)) or in certain circumstances did not intend to enhance his or her sport performance (Article 10.4 (Elimination or Reduction of the Period of Ineligibility for Specified Substances under Specific Circumstances)). The strict liability rule for the finding of a Prohibited Substance in an Athlete's Sample, with a possibility that sanctions may be modified based on specified criteria, provides a reasonable balance between effective anti-doping enforcement for the benefit of all "clean" Athletes and fairness in the exceptional circumstance where a Prohibited Substance entered an Athlete's system through No Fault or Negligence or No Significant Fault or Negligence on the Athlete's part. It is important to emphasize that while the determination of whether the anti-doping rule WBPF Anti-Doping Rules
August 2009

violation has occurred is based on strict liability, the imposition of a fixed period of Ineligibility is not automatic. The strict liability principle set forth in these Anti-Doping Rules has been consistently upheld in the decisions of CAS.] 2.1.2 Sufficient proof of an anti-doping rule violation under Article 2.1 is
established by either of the following: presence of a Prohibited Substance or its
Metabolites or Markers in the Athlete's A Sample where the Athlete waives
analysis of the B Sample and the B Sample is not analyzed; or, where the Athlete's
B Sample is analyzed and the analysis of the Athlete's B Sample confirms the
presence of the Prohibited Substance or its Metabolites or Markers found in the
Athlete's A Sample.
[Comment to Article 2.1.2: The Anti-Doping Organization with results management responsibility may in its discretion choose to have the B Sample analyzed even if the Athlete does not request the analysis of the B Sample.] 2.1.3 Excepting those substances for which a quantitative threshold is specifically
identified in the Prohibited List, the presence of any quantity of a Prohibited
Substance
or its Metabolites or Markers in an Athlete's Sample shall constitute an
anti-doping rule violation.
2.1.4 As an exception to the general rule of Article 2.1, the Prohibited List or
International Standards may establish special criteria for the evaluation of
Prohibited Substances that can also be produced endogenously.
2.2
Use or Attempted Use by an Athlete of a Prohibited Substance or a Prohibited
[Comment to Article 2.2: It has always been the case that Use or Attempted Use of a Prohibited Substance or Prohibited Method may be established by any reliable means. As noted in the Comment to Article 3.2 (Methods of Establishing Facts and Presumptions), unlike the proof required to establish an anti-doping rule violation under Article 2.1, Use or Attempted Use may also be established by other reliable means such as admissions by the Athlete, witness statements, documentary evidence, conclusions drawn from longitudinal profiling, or other analytical information which does not otherwise satisfy all the requirements to establish "Presence" of a Prohibited Substance under Article 2.1. For example, Use may be established based upon reliable analytical data from the analysis of an A Sample (without confirmation from an analysis of a B Sample) or from the analysis of a B Sample alone where the Anti-Doping Organization provides a satisfactory explanation for the lack of confirmation in the other Sample.] It is each Athlete's personal duty to ensure that no Prohibited Substance enters his or her body. Accordingly, it is not necessary that intent, fault, negligence or knowing Use on the Athlete's part be demonstrated in order to WBPF Anti-Doping Rules
August 2009

establish an anti-doping rule violation for Use of a Prohibited Substance or a Prohibited Method. The success or failure of the Use or Attempted Use of a Prohibited Substance or Prohibited Method is not material. It is sufficient that the Prohibited Substance or Prohibited Method was Used or Attempted to be Used for an anti-doping rule violation to be committed. [Comment to Article 2.2.2: Demonstrating the "Attempted Use" of a Prohibited Substance requires proof of intent on the Athlete's part. The fact that intent may be required to prove this particular anti-doping rule violation does not undermine the strict liability principle established for violations of Article 2.1 and violations of Article 2.2 in respect of Use of a Prohibited Substance or Prohibited Method. An Athlete's "Use" of a Prohibited Substance constitutes an anti-doping rule violation unless such substance is not prohibited Out-of-Competition and the Athlete's Use takes place Out-of-Competition. (However, the presence of a Prohibited Substance or its Metabolites or Markers in a Sample collected In-Competition is a violation of Article 2.1 (Presence of a Prohibited Substance or its Metabolites or Markers) regardless of when that substance might have been administered.)] Refusing or failing without compelling justification to submit to Sample
collection after notification as authorized in these Anti-Doping Rules, or otherwise
evading Sample
collection.
[Comment to Article 2.3: Failure or refusal to submit to Sample collection WBPF notification was prohibited in almost all pre-Code anti-doping rules. This Article expands the typical pre-Code rule to include "otherwise evading Sample collection" as prohibited conduct. Thus, for example, it would be an anti-doping rule violation if it were established that an Athlete was hiding from a Doping Control official to evade notification or Testing. A violation of "refusing or failing to submit to Sample collection" may be based on either intentional or negligent conduct of the Athlete, while "evading" Sample collection contemplates intentional conduct by the Athlete.] Violation of applicable requirements regarding Athlete availability for Out-of-
Competition Testing, including failure to file required whereabouts information and
missed tests which are declared based on rules which comply with the International
Standard
for Testing. Any combination of three missed tests and/or filing failures
within an eighteen-month period as determined by Anti-Doping Organizations
with
jurisdiction over the Athlete
shall constitute an anti-doping rule violation.
[Comment to Article 2.4: Separate whereabouts filing failures and missed tests declared under the rules of IF or any other Anti-Doping Organization with authority to declare whereabouts filing failures and missed tests in accordance with the International Standard for Testing shall be WBPF Anti-Doping Rules
August 2009

combined in applying this Article. In appropriate circumstances, missed tests or filing failures may also constitute an anti-doping rule violation under Article 2.3 or Article 2.5.] 2.5
Tampering or Attempted Tampering with any part of Doping Control.
[Comment to Article 2.5: This Article prohibits conduct which subverts the Doping Control process but which would not otherwise be included in the definition of Prohibited Methods. For example, altering identification numbers on a Doping Control form during Testing, breaking the B Bottle at the time of B Sample analysis or providing fraudulent information to an Anti-Doping Organization.] 2.6
Possession of Prohibited Substances and Methods
2.6.1 Possession by an Athlete In-Competition of any Prohibited Method or any
Prohibited Substance
, or Possession by an Athlete Out-of-Competition of any
Prohibited Method
or any Prohibited Substance which is prohibited Out-of-
Competition
unless the Athlete establishes that the Possession is pursuant to a
therapeutic use exemption ("TUE") granted in accordance with Article 4.4
(Therapeutic Use) or other acceptable justification.
2.6.2 Possession by an Athlete Support Personnel In-Competition of any
Prohibited Method
or any Prohibited Substance, or Possession by an Athlete
Support Personnel
Out-of-Competition of any Prohibited Method or any
Prohibited Substance
which is prohibited Out-of-Competition, in connection with
an Athlete, Competition or training, unless the Athlete Support Personnel
establishes that the Possession is pursuant to a TUE granted to an Athlete in
accordance with Article 4.4 (Therapeutic Use) or other acceptable justification.
[Comment to Article 2.6.1 and 2.6.2: Acceptable justification would not include, for example, buying or possessing a Prohibited Substance for purposes of giving it to a friend or relative, except under justifiable medical circumstances where that Person had a physician's prescription, e.g., buying Insulin for a diabetic child.] [Comment to Article 2.6.2: Acceptable justification would include, for example, a team doctor carrying Prohibited Substances for dealing with acute and emergency situations.] 2.7
Trafficking or Attempted Trafficking in any Prohibited Substance or Prohibited
Administration or Attempted administration to any Athlete In-Competition of
any Prohibited Method or Prohibited Substance, or administration or Attempted
administration to any Athlete
Out-of-Competition of any Prohibited Method or any
Prohibited Substance
that is prohibited Out-of-Competition, or assisting, encouraging,
aiding, abetting, covering up or any other type of complicity involving an anti-doping
rule violation or any Attempted
anti-doping rule violation.
WBPF Anti-Doping Rules
August 2009

[Comment to Article 2: The Code does not make it an anti-doping rule violation for an Athlete or other Person to work or associate with Athlete Support Personnel who are serving a period of Ineligibility. However, IF may adopt its own specific policy which prohibit such conduct. [Please insert here specific rules to that effect if applicable] ARTICLE 3 PROOF OF DOPING
Burdens and Standards of Proof
WBPF and its National Federations shall have the burden of establishing that an anti-doping rule violation has occurred. The standard of proof shall be whether IF or its National Federation has established an anti-doping rule violation to the comfortable satisfaction of the hearing panel bearing in mind the seriousness of the allegation which is made. This standard of proof in all cases is greater than a mere balance of probability but less than proof beyond a reasonable doubt. Where these Rules place the burden of proof upon the Athlete or other Person alleged to have committed an anti-doping rule violation to rebut a presumption or establish specified facts or circumstances, the standard of proof shall be by a balance of probability, except as provided in Articles 10.4 and 10.6, where the Athlete must satisfy a higher burden of proof. [Comment to Article 3.1: This standard of proof required to be met by WBPF or its National Federation is comparable to the standard which is applied in most countries to cases involving professional misconduct. It has also been widely applied by courts and hearing panels in doping cases. See, for example, the CAS decision in N., J., Y., W. v. FINA, CAS 98/208, 22 December 1998.] Methods of Establishing Facts and Presumptions
Facts related to anti-doping rule violations may be established by any reliable means, including admissions. The following rules of proof shall be applicable in doping cases: [Comment to Article 3.2: For example, WBPF or its National Federation may establish an anti-doping rule violation under Article 2.2 (Use or Attempted Use of a Prohibited Substance or Prohibited Method) based on the Athlete's admissions, the credible testimony of third Persons, reliable documentary evidence, reliable analytical data from either an A or B Sample as provided in the Comments to Article 2.2, or conclusions drawn from the profile of a series of the Athlete's blood or urine Samples.] 3.2.1 WADA-accredited laboratories are presumed to have conducted Sample
analysis and custodial procedures in accordance with the International Standard
for Laboratories. The Athlete or other Person may rebut this presumption by
establishing that a departure from the International Standard for Laboratories
occurred which could reasonably have caused the Adverse Analytical Finding.
WBPF Anti-Doping Rules
August 2009

If the Athlete or other Person rebuts the preceding presumption by showing that a departure from the International Standard for Laboratories occurred which could reasonably have caused the Adverse Analytical Finding, then IF or its National Federation shall have the burden to establish that such departure did not cause the Adverse Analytical Finding. [Comment to Article 3.2.1: The burden is on the Athlete or other Person to establish, by a balance of probability, a departure from the International Standard that could reasonably have caused the Adverse Analytical Finding. If the Athlete or other Person does so, the burden shifts to WBPF or its National Federation to prove to the comfortable satisfaction of the hearing panel that the departure did not cause the Adverse Analytical Finding.] 3.2.2 Departures from any other International Standard for Laboratories or
other anti-doping rule or policy which did not cause an Adverse Analytical
Finding
or other anti-doping rule violation shall not invalidate such results. If the
Athlete or other Person establishes that a departure from another International
Standard
or other anti-doping rule or policy which could reasonably have caused
the Adverse Analytical Finding or other anti-doping rule violation occurred, then
WBPF or its National Federation shall have the burden to establish that such a
departure did not cause the Adverse Analytical Finding or the factual basis for the
anti-doping rule violation.
3.2.3 The facts established by a decision of a court or professional disciplinary
tribunal of competent jurisdiction which is not the subject of a pending appeal
shall be irrebuttable evidence against the Athlete or other Person to whom the
decision pertained of those facts unless the Athlete or other Person establishes that
the decision violated principles of natural justice.
3.2.4 The hearing panel in a hearing on an anti-doping rule violation may draw an
inference adverse to the Athlete or other Person who is asserted to have
committed an anti-doping rule violation based on the Athlete's or other Person's
refusal, after a request made in a reasonable time in advance of the hearing, to
appear at the hearing (either in person or telephonically as directed by the hearing
panel) and to answer questions either from the hearing panel or from the Anti-
Doping Organization
asserting the anti-doping rule violation.
[Comment to Article 3.2.4: Drawing an adverse inference under these circumstances has been recognized in numerous CAS decisions.] ARTICLE 4 THE PROHIBITED LIST
Incorporation of the Prohibited List
These Anti-Doping Rules incorporate the Prohibited List which is published and revised by WADA as described in Article 4.1 of the Code. WBPF will make the current Prohibited List WBPF Anti-Doping Rules
August 2009

available to each National Federation, and each National Federation shall ensure that the current Prohibited List is available to its members and constituents. [Comment to Article 4.1: The Prohibited List will be revised and published on an expedited basis whenever the need arises. However, for the sake of predictability, a new Prohibited List will be published every year whether or not changes have been made. The Prohibited List in force is available on WADA's website at www.wada-ama.org.The Prohibited List is an integral part of the International Convention against Doping in Sport. Prohibited Substances and Prohibited Methods Identified on the Prohibited List
4.2.1 Prohibited Substances and Prohibited Methods
Unless provided otherwise in the Prohibited List and/or a revision, the Prohibited List and revisions shall go into effect under these Anti-Doping Rules three months after publication of the Prohibited List by WADA without requiring any further action by WBPF or its National Federations. As described in Article 4.2 of the Code, WBPF may request that WADA expand the Prohibited List for the sport of bodybuilding, fitness physique, athletic physique and model physique. WBPF may also request that WADA include additional substances or methods, which have the potential for abuse in the sport of bodybuilding, fitness physique, athletic physique and model physique, in the monitoring program described in Article 4.5 of the Code. As provided in the Code, WADA shall make the final decision on such requests by WBPF. 4.2.2 Specified Substances
For purposes of the application of Article 10 (Sanctions on Individuals), all
Prohibited Substances shall be "Specified Substances" except (a) substances in the
classes of anabolic agents and hormones; and (b) those stimulants and hormone
antagonists and modulators so identified on the Prohibited List. Prohibited Methods
shall not be Specified Substances.
4.2.3 New Classes of Prohibited Substances
In the event WADA expands the Prohibited List by adding a new class of Prohibited
Substances in accordance with Article 4.1 of the Code, WADA's Executive
Committee shall determine whether any or all prohibited Substances within the new
class of Prohibited Substances shall be considered Specified Substances under
Article 4.2.2.
4.3
Criteria for Including Substances and Methods on the Prohibited List
WBPF Anti-Doping Rules
August 2009

As provided in Article 4.3.3 of the Code, WADA's determination of the Prohibited Substances and Prohibited Methods that will be included on the Prohibited List and the classification of substances into categories on the Prohibited List is final and shall not be subject to challenge by an Athlete or other Person based on an argument that the substance or method was not a masking agent or did not have the potential to enhance performance, represent a health risk or violate the spirit of sport. Therapeutic Use
4.4.1 Athletes with a documented medical condition requiring the use of a
Prohibited Substance or a Prohibited Method must first obtain a TUE. The
presence of a Prohibited Substance or its Metabolites or Markers (Article 2.1),
Use
or Attempted Use of a Prohibited Substance or a Prohibited Method (Article
2.2), Possession of Prohibited Substances or Prohibited Methods (Article 2.6) or
Administration or Attempted Administration of a Prohibited Substance or
Prohibited Method
(Article 2.8) consistent with the provisions of an applicable
TUE issued pursuant to the International Standard for Therapeutic Use
Exemptions shall not be considered an anti-doping rule violation.
4.4.2 Subject to Article 4.4.4, Athletes included by WBPF in its Registered
Testing Pool
and other Athletes participating in an International Event identified
by WBPF must obtain a TUE from WBPF (regardless of whether the Athlete
previously has received a TUE at the national level). The application for a TUE
must be made as soon as possible (in the case of an Athlete in the Registered
Testing Pool
, this would be when he/she is first notified of his/her inclusion in the
pool) and in any event (save in emergency situations) no later than 21 days before
the Athlete's participation in the Event. TUE granted by WBPF shall be reported
to the Athlete's National Federation and to WADA.
4.4.3 Subject to Article 4.4.4, Athletes who are not included by WBPF in its
Registered Testing Pool must obtain a TUE from their National Anti-Doping
Organization
or other body designated by their National Federation, as required
under the rules of the National Anti-Doping Organization or the National
Federation
. The application for a TUE must be made as soon as possible (in the
case of an Athlete in the Registered Testing Pool, this would be when he/she is
first notified of his/her inclusion in the pool) and in any event (save in emergency
situations) no later than 21 days before the Athlete's participation in the Event.
National Federations shall promptly report any such TUE to WBPF and WADA.
4.4.4 As an exception to Articles 4.4.2 and 4.4.3, the Use of inhaled
formoterol,
Glucocorticosteroids by non systemic routes namely, intraarticular, periarticular, peritendinous, epidural, intradermal injections and inhaled route may be authorized according to specific procedures outlined under Articles 7.13 and 8 of the International Standard for Therapeutic Use Exemptions. WBPF Anti-Doping Rules
August 2009

4.4.4.1 In accordance with Article 7.13 of the International Standard for
Therapeutic Use Exemptions, the use of inhaled formoterol, salbutamol, salmeterol or terbutaline to treat asthma or one of its clinical variants may be authorized according to the following rules For all Athletes included in the WBPF Registered Testing Pool, a regular TUE needs to be approved before the Use of the substance; - For national-level Athletes who are not included in the WBPF Registered Testing Pool, whether or not they are part of a national Registered Testing Pool, a TUE may be required before the Use of the substance or not, in accordance with the rules of the National Anti-Doping Organization or the National Federation. 4.4.4.2 The Use of Glucocorticosteroids by non systemic routes namely,
intraarticular, periarticular, peritendinous, epidural, intradermal injections and inhaled route may be authorized in accordance with Declaration of Use Process described under Article 8 of the International Standard for Therapeutic Use Exemptions. 4.4.5 WBPF shall appoint a panel to consider requests for TUE's (the "TUE
Panel") in accordance with the International Standard for Therapeutic Use
Exemptions. The TUE Panel member(s) shall promptly evaluate the request in
accordance with the International Standard for Therapeutic Use Exemptions and
render a decision on such request, which shall be the final decision of WBPF.
4.4.6 WADA, on its own initiative, may review at any time the granting of a
TUE to any International-Level Athlete or national-level Athlete who is included
in his or her National Anti-Doping Organization or National Federation's
Registered Testing Pool. Further, upon any request of any such Athlete who has
been denied a TUE, WADA may review such denial. If WADA determines that
such granting or denial of a TUE did not comply with the International Standard
for Therapeutic Use Exemptions, WADA may reverse that decision. Decisions on
TUE's are subject to further appeal as provided in Article 13.
ARTICLE 5 TESTING
Authority to Test
All Athletes under the jurisdiction of a National Federation shall be subject to Testing by WBPF, the Athlete's National Federation, and any other Anti-Doping Organization responsible for Testing at a Competition or Event in which they participate. All Athletes under the jurisdiction of a National Federation, including Athletes serving a period of ineligibility or a Provisional Suspension, shall be subject to Testing at any time or place, with or without advance notice, In-Competition or Out-of-Competition by WBPF, WADA, the Athlete's National Federation, the National Anti-Doping Organization of any country WBPF Anti-Doping Rules
August 2009

where the Athlete is present or of which the Athlete is national, resident, or member of a sport organization, the IOC in connection with the Olympic Games, the IPC in connection with Paralympic Games, and any other Anti-Doping Organization responsible for Testing at a Competition or Event in which they participate. All Athletes must comply with any request for Testing by any Anti-Doping Organization with Testing jurisdiction. Test Distribution Plan
In coordination with other Anti-Doping Organizations conducting Testing on the same Athletes, and consistent with the International Standard for Testing, WBPF and its National Federations shall: 5.2.1 Plan and conduct an effective number of In-Competition and Out-of-Competition tests on Athletes over whom they have jurisdiction, including but not limited to Athletes in their respective Registered Testing Pools. 5.2.2 Except in exceptional circumstances all Out-of-Competition Testing shall be No Advance Notice. 5.2.3 Make Target Testing a priority. 5.2.4 Conduct Testing on Athletes serving a period of Ineligibility or a Provisional Suspension. 5.3
Standards for Testing
Testing conducted by WBPF and its National Federations shall be in substantial conformity with the International Standard for Testing in force at the time of Testing. 5.3.1 Blood (or other non-urine) Samples may be used to detect Prohibited
Substances
or Prohibited Methods, for screening procedure purposes, or for
longitudinal hematological profiling ("the passport").
Coordination of Testing
5.4.1 Event Testing The collection of Samples for Doping Control shall take place at both International Events and National Events. However, except as otherwise provided below, only a single organization should be responsible for initiating and directing Testing during the Event Period. At International Events, the collection of Doping Control Samples shall be initiated and directed by the international organization which is the ruling body for the Event (e.g., the International Olympic Committee for the Olympic Games, WBPF for a World Championship, Continental Federations for Continental Championships and Pan-American Sports Organisation for the Pan American Games). At National Events, the WBPF Anti-Doping Rules
August 2009

collection of Doping Control Samples shall be initiated and directed by the designated National Anti-Doping Organization or National Federation of that country. 5.4.1.1 If WBPF or its National Federations nevertheless desires to conduct additional Testing of Athletes at an Event for which they are not responsible for initiating and directing Testing during the Event Period, IF or its National Federations shall first confer with the ruling body of the Event to obtain permission to conduct, and to coordinate, any additional Testing. If WBPF or its National Federations are not satisfied with the response from the ruling body of the Event, WBPF or its National Federations may ask WADA for permission to conduct additional Testing and to determine how to coordinate such additional Testing. 5.4.2 Out-of-Competition Testing Out-of-Competition Testing shall be initiated and directed by both international and national organizations. Out-of-Competition Testing may be initiated and directed by: (a) WADA; (b) the International Olympic Committee or International Paralympic Committee in connection with the Olympic Games or Paralympic Games; (c) WBPF Continental Federations or the Athlete's National Federation; or (d) any other Anti-Doping Organization that has Testing jurisdiction over the Athlete as provided in Article 5.1 (Authority to Test). Out-of-Competition Testing shall be coordinated through ADAMS where reasonably feasible in order to maximize the effectiveness of the combined Testing effort and to avoid unnecessary repetitive Testing of individual Athletes. 5.4.3 Report WBPF and National Federations shall promptly report completed tests through the WADA clearinghouse in accordance with article 14.5 to avoid unnecessary duplication in Testing. Athlete Whereabouts Requirements
5.5.1 WBPF shall identify a Registered Testing Pool of those Athletes who are
required to comply with the whereabouts requirements of the International
Standard for Testing, and shall publish the criteria for Athletes to be included in
this Registered Testing Pool as well as a list of the Athletes meeting those criteria
for the period in question. WBPF shall review and update as necessary its criteria
for including Athletes in its Registered Testing Pool, and shall revise the
membership of its Registered Testing Pool from time to time as appropriate in
accordance with the set criteria. Each Athlete in the Registered Testing Pool (a)
shall advise WBPF of his/her whereabouts on a quarterly basis, in the manner set
out in Article 11.3 of the International Standard for Testing; (b) shall update that
information as necessary, in accordance with Article 11.4.2 of the International
WBPF Anti-Doping Rules
August 2009

Standard for Testing, so that it remains accurate and complete at all times; and (c) shall make him/herself available for Testing at such whereabouts, in accordance with Article 11.4 of the International Standard for Testing. Members of the WBPF Registered Testing Pool are: medal winners of the latest World and Continental Championships medal winners of IOC recognized Games  WBPF Medical and Anti-Doping Committee can include any other Athlete, Member of National Team in the Registered Testing Pool by written notice to the National Federation of the Athlete concerned.  If an Athlete no longer fulfills any of the above criteria, he will remain in the Registered Testing Pool until end of the Calendar year.  The list of Athletes in the Registered Testing Pool shall be available on the WBPF website. [Comment to Article 5.5.1: The purpose of the WBPF Registered Testing Pool is to identify top-level International Athletes who the WBPF requires to provide whereabouts information to facilitate Out-of-Competition Testing by WBPF and other Anti-Doping Organizations with jurisdiction over the Athletes. WBPF will identify such Athletes in accordance with the requirements of Articles 4 and 11.2 of the International Standard for Testing. Every National Federation shall report to IF [the performances, names and addresses of all Athletes whose performances fall within the Registered Testing Pool criteria established by WBPF].] 5.5.2 An Athlete's failure to advise WBPF of his/her whereabouts shall be
deemed a filing failure for purposes of Article 2.4 where the conditions of Article
11.3.5 of the International Standard for Testing are met.
5.5.3 An Athlete's failure to be available for Testing at his/her declared
whereabouts shall be deemed a missed test for purposes of Article 2.4 where the
conditions of Article 11.4.3 of the International Standard for Testing are met.
5.5.4 Each National Federation shall also assist its National Anti-Doping
Organization
in establishing a national level Registered Testing Pool of top level
national Athletes to whom the whereabouts requirements of the International
Standard
for Testing shall also apply. Where those Athletes are also in the
WBPF's Registered Testing Pool, the WBPF and the National Anti-Doping
Organization
will agree (with the assistance of WADA if required) on which of
them will take responsibility for receiving whereabouts filings from the Athlete
and sharing it with the other (and with other Anti-Doping Organizations) in
accordance with Article 5.5.5.
WBPF Anti-Doping Rules
August 2009

5.5.5 Whereabouts information provided pursuant to Articles 5.5.1 and 5.5.4
shall be shared with WADA and other Anti-Doping Organizations having
jurisdiction to test an Athlete in accordance with Articles 11.7.1(d) and 11.7.3(d)
of the International Standard for Testing, including the strict condition that it be
used only for Doping Control purposes.
Retirement and Return to Competition
5.6.1 An Athlete who has been identified by WBPF for inclusion in WBPF's
Registered Testing Pool shall continue to be subject to these Anti-Doping Rules,
including the obligation to comply with the whereabouts requirements of the
International Standard for Testing unless and until the Athlete gives written
notice to WBPF that he or she has retired or until he or she no longer satisfies the
criteria for inclusion in WBPF's Registered Testing Pool and has been so
informed by IF.
5.6.2 An Athlete who has given notice of retirement to WBPF may not resume
competing unless he or she notifies WBPF at least six (6) months before he or she
expects to return to competition and makes him/herself available for unannounced
Out-of-Competition Testing, including (if requested) complying with the
whereabouts requirements of the International Standard for Testing, at any time
during the period before actual return to competition.
5.6.3 National Federations/National Anti-Doping Organizations may establish
similar requirements for retirement and returning to competition for Athletes in
the national Registered Testing Pool.
Selection of Athletes to be Tested
5.7.1 At International Events, WBPF Medical and Anti-Doping Committee
shall determine the number of finishing placement tests, random tests and target
tests to be performed. The WBPF shall target a certain number of Athletes not
necessarily linked to final placements in order to maximize the diversity of
Athletes tested.
5.7.2 At National, Regional and Continental Events, the Medical or Anti-
Doping Committee of each National, Regional or Continental Federation shall
determine the number of Athletes selected for Testing in each Competition and the
procedures for selecting the Athletes for Testing.
5.7.3 In addition to the selection procedures set forth in Articles 5.7.1 and 5.7.2
above, WBPF Medical and Anti-Doping Committee at International Events, and
the National Federation at National Events, may also select Athletes for Target
Testing
so long as such Target Testing is not used for any purpose other than
legitimate Doping Control purposes.
5.7.4 Athletes shall be selected for Out-of-Competition Testing by the WBPF
Medical and Anti-Doping Committee and by National Federations through a
WBPF Anti-Doping Rules
August 2009

process that substantially complies with the International Standard for Testing in force at the time of selection. 5.8 WBPF and the organizing committees for WBPF Events, as well as the National
Federations
and the organizing committees for National Federation Events, shall provide
access to independent observers at Events in accordance with the Independent Observers
Program
.
5.9 An Athlete who is not regular member of WBPF or one of its National Federations
will not be permitted to compete unless he or she is available for Sample collection and
where applicable, he/she provides accurate and up-to-date whereabouts information as
part of the WBPF's a National Federation's Registered Testing Pool at least two months
before he or she expects to compete.
ARTICLE 6 ANALYSIS OF SAMPLES
Doping Control Samples collected under these Anti-Doping Rules shall be analyzed in accordance with the following principles: Use of Approved Laboratories
For purposes of Article 2.1 (Presence of a Prohibited Substance or its Metabolites or Markers), WBPF or its National Federations shall send Samples for analysis only to WADA-accredited laboratories or as otherwise approved by WADA. The choice of the WADA-accredited laboratory (or other laboratory or method approved by WADA) used for the Sample analysis shall be determined exclusively by WBPF or its National Federations. Purpose of Collection and Analysis of Samples
Samples shall be analyzed to detect Prohibited Substances and Prohibited Methods identified on the Prohibited List and other substances as may be directed by WADA pursuant to the Monitoring Program described in Article 4.5 of the Code or to assist WBPF or its National Federations in profiling relevant parameters in an Athlete's urine, blood or other matrix, including DNA or genomic profiling, for anti-doping purposes. Research on Samples
No Sample may be used for any purpose other than as described in Article 6.2 without the Athlete's written consent. Samples used (with the Athlete's consent) for purposes other than Article 6.2 shall have any means of identification removed such that they cannot be traced back to a particular Athlete. Standards for Sample Analysis and Reporting
Laboratories shall analyze Doping Control Samples and report results in conformity with the International Standard for Laboratories. WBPF Anti-Doping Rules
August 2009

6.5 Retesting Samples
A Sample may be reanalyzed for the purposes described in Article 6.2 at any time
exclusively at the direction of the Anti-Doping Organization that collected the Sample or
WADA. The circumstances and conditions for retesting Samples shall conform with the
requirements of the International Standard for Laboratories.
ARTICLE 7 RESULTS MANAGEMENT
Results Management for Tests Initiated by WBPF
Results management for tests initiated by WBPF (including tests performed by WADA pursuant to agreement with WBPF) shall proceed as set forth below: 7.1.1 The results from all analyses must be sent to WBPF in encoded form, in a
report signed by an authorised representative of the laboratory. All communication
must be conducted in confidentiality and in conformity with ADAMS, a database
management tool developed by WADA. ADAMS is consistent with data privacy
statutes and norms applicable to WADA and other organizations using it.
7.1.2 Upon receipt of an A Sample Adverse Analytical Finding, WBPF shall
conduct an initial review to determine whether: (a) an applicable TUE has been
granted or will be granted as provided in the International Standard for Therapeutic
Use Exemptions, or (b) there is any apparent departure from the International
Standard
for Testing or International Standard for Laboratories that caused the
Adverse Analytical Finding.
7.1.2.1 The WBPF Executive Council shall appoint a Doping Review
Panel consisting of a Chair and four (4) other members with experience in
anti-doping. Each panel member shall serve a term of four years. In each
case the Chair of the panel shall appoint 1 or more members of the panel
(which may include the Chair) to conduct the review discussed in Articles
7.1.2 and 7.1.8 and to review any other potential violations of these Anti-
Doping Rules as may be requested by WBPF.
7.1.3 When the Adverse Analytical Finding is for formoterol, salbutamol,
salmeterol or terbutaline and the Athlete, in view of his category, does not need a
regular TUE before the Use of the substance in accordance with Article 4.4.4 and
Article 7.13 of the International Standard for Therapeutic Use Exemptions, then,
before WBPF completes its review under Article 7.1.2, the Athlete shall be given
an opportunity to apply to the TUE Panel for a Retroactive TUE in accordance
with Article 7.13 of the International Standard for Therapeutic Use Exemptions.
When the Adverse Analytical Finding is for a Glucocorticosteroid, WBPF shall
check whether that a declaration of use is in place for the non-systemic use of
Glucocorticosteroids.
WBPF Anti-Doping Rules
August 2009

7.1.4 If the initial review of an Adverse Analytical Finding under Article 7.1.2
does not reveal an applicable TUE or entitlement to a TUE as provided in the
International Standard for Therapeutic Use Exemptions, or departure that caused the
Adverse Analytical Finding, WBPF shall promptly notify the Athlete, in the manner
set out in Article 19, of: (a) the Adverse Analytical Finding; (b) the anti-doping rule
violated; (c) the Athlete's right to promptly request the analysis of the B Sample or,
failing such request, that the B Sample analysis may be deemed waived; (d) the
scheduled date, time and place for the B Sample analysis if the Athlete or IF chooses
to request an analysis of the B Sample; (e) the opportunity for the Athlete and/or the
Athlete's representative to attend the B Sample opening and analysis within the time
period specified in the International Standard for Laboratories if such analysis is
requested; and (f) the Athlete's right to request copies of the A and B Sample
laboratory documentation package which includes information as required by the
International Standard for Laboratories. WBPF shall also notify the Athlete's
National Anti-Doping Organization and WADA. If WBPF decides not to bring
forward the Adverse Analytical Finding as an anti-doping rule violation, it shall so
notify the Athlete, the Athlete's National Anti-Doping Organization and WADA.
7.1.5 Where requested by the Athlete or WBPF, arrangements shall be made for
Testing the B Sample within the time period specified in the International Standard
for Laboratories. An Athlete may accept the A Sample analytical results by waiving
the requirement for B Sample analysis. WBPF may nonetheless elect to proceed
with the B Sample analysis.
7.1.6 The Athlete and/or his representative shall be allowed to be present at the
analysis of the B Sample within the time period specified in the International
Standard
for Laboratories. Also a representative of the Athlete's National Federation
as well as a representative of WBPF shall be allowed to be present.
7.1.7 If the B Sample proves negative, then (unless WBPF takes the case forward
as an anti-doping rule violation under Article 2.2) the entire test shall be considered
negative and the Athlete, his National Federation, and WBPF IF shall be so
informed.
7.1.8 If a Prohibited Substance or the Use of a Prohibited Method is identified,
the findings shall be reported to the Athlete, his National Federation, WBPF, and to
WADA.
7.1.9 WBPF shall conduct any follow-up investigation into a possible anti-
doping rule violation not covered by Articles 7.1.1 to 7.1.8. At such time as WBPF
is satisfied that an anti-doping rule violation has occurred, it shall promptly give the
Athlete or other Person subject to sanction notice, in the manner set out in Article
19, of the anti-doping rule violated, and the basis of the violation. WBPF shall also
notify the Athlete's National Anti-Doping Organization and WADA.
WBPF Anti-Doping Rules
August 2009

Review of Atypical Findings
7.2.1 As provided in the International Standards, in some circumstances
laboratories are directed to report the presence of Prohibited Substances, which may
also be produced endogenously as Atypical Findings subject to further investigation.
7.2.2 Upon receipt of an A Sample Atypical Finding, WBPF shall conduct an
initial review to determine whether: (a) an applicable TUE has been granted, or (b)
there is any apparent departure from the International Standard for Testing or
International Standard for Laboratories that caused the Atypical Finding.
7.2.3 If the initial review of an Atypical Finding under Article 7.2.2 reveals an
applicable TUE or departure from the International Standard for Testing or the
International Standard for Laboratories that caused the Atypical Finding, the entire
test shall be considered negative and the Athlete, the Athlete's National Anti-Doping
Organization
, and WADA shall be so informed.
7.2.4 If that initial review does not reveal an applicable TUE or departure that
caused the Atypical Finding, WBPF shall conduct the required investigation. After
the investigation is completed, the Athlete, WADA and the Athlete's National Anti-
Doping Organization
shall be notified whether or not the Atypical Finding will be
brought forward as an Adverse Analytical Finding. The Athlete shall be notified as
provided in Article 7.1.4.
7.2.5 WBPF will not provide notice of an Atypical Finding until it has completed
its investigation and has decided whether it will bring the Atypical Finding forward
as an Adverse Analytical Finding unless one of the following circumstances exists:
(a) If WBPF determines the B Sample should be analyzed prior to the conclusion of its follow-up investigation, it may conduct the B Sample analysis after notifying the Athlete, with such notice to include a description of the Atypical Finding and the information described in Article 7.1.4(b) to (f). (b) If WBPF receives a request, either from a Major Event Organization shortly before one of its International Events or a request from a sport organization responsible for meeting an imminent deadline for selecting team members for an International Event, to disclose whether any Athlete identified on a list provided by the Major Event Organization or sport organization has a pending Atypical Finding, WBPF shall so identify any such Athlete after first providing notice of the Atypical Finding to the Athlete. Results Management for Tests Initiated During Other International Events
Results management and the conduct of hearings from a test by the International Olympic Committee, the International Paralympic Committee, or a Major Event Organization, shall be managed, as far as sanctions beyond Disqualification from the Event or the results of the Event, by WBPF. WBPF Anti-Doping Rules
August 2009

Results Management for Tests initiated by National Federations
Results management conducted by National Federations shall be consistent with the general principles for effective and fair results management which are underlined in the detailed provisions set forth in this Article 7. Adverse Analytical findings, Atypical Findings and other asserted violations of anti-doping rules shall be reported by National Federations in accordance with the principles outlined in this Article 7 to the Athlete's National Anti-Doping Organization, WBPF and WADA no later than the completion of the National Federation's results management process. Any apparent anti-doping rule violation by an Athlete who is a member of that National Federation shall be promptly referred to an appropriate hearing panel established pursuant to the rules of the National Federation, National Anti-Doping Organization or national law. Apparent anti-doping rule violations by Athletes who are members of another National Federation shall be referred to the Athlete's National Federation for hearing. Results Management for Whereabouts Violations
7.5.1 Results management in respect of an apparent Filing Failure by an Athlete
in WBPF's Registered Testing Pool shall be conducted by WBPF in accordance
with Article 11.6.2 of the International Standard for Testing (unless it has been
agreed in accordance with Article 5.5.4 that the National Federation or National
Anti-Doping Organization
shall take such responsibility).
7.5.2 Results management in respect of an apparent Missed Test by an Athlete in
WBPF's Registered Testing Pool as a result of an attempt to test the Athlete by or on
behalf of WBPF shall be conducted by WBPF in accordance with Article 11.6.3 of
the International Standard for Testing. Results management in respect of an
apparent Missed Test by such Athlete as a result of an attempt to test the Athlete by
or on behalf of another Anti-Doping Organization shall be conducted by that other
Anti-Doping Organization in accordance with Article 11.7.6(c) of the International
Standard
for Testing.
7.5.3 Where, in any eighteen-month period, an Athlete in WBPF's Registered
Testing Pool
is declared to have three Filing Failures, or three Missed Tests, or any
combination of Filing Failures or Missed Tests adding up to three in total, whether
under these Anti-Doping Rules or under the rules of any other Anti-Doping
Organization
, WBPF shall bring them forward as an apparent anti-doping rule
violation.
Provisional Suspensions
7.6.1 If analysis of an A Sample has resulted in an Adverse Analytical Finding
for a Prohibited Substance that is not a Specified Substance, and a review in
accordance with Article 7.1.2 does not reveal an applicable TUE or departure from
the International Standard for Testing or the International Standard for Laboratories
that caused the Adverse Analytical Finding, a Provisional Suspension shall be
imposed promptly after the review and notification described in Article 7.1.
WBPF Anti-Doping Rules
August 2009

7.6.2 In any case not covered by Article 7.6.1 where WBPF decides to take the
matter forward as an apparent anti-doping rule violation in accordance with the
foregoing provisions of this Article 7, a Provisional Suspension may be imposed
after the review and notification described in Article 7.1, but prior to the analysis of
the Athlete's B Sample or the final hearing as described in Article 8 (Right to a Fair
Hearing).
7.6.3 However, a Provisional Suspension may not be imposed, whether pursuant
to Article 7.6.1 or Article 7.6.2, unless the Athlete or other Person is given either (a)
an opportunity for a Provisional Hearing either before imposition of the Provisional
Suspension
or on a timely basis after imposition of the Provisional Suspension; or
(b) an opportunity for an expedited hearing in accordance with Article 8 (Right to a
Fair Hearing) on a timely basis after imposition of a Provisional Suspension.
National Federations shall impose Provisional Suspensions in accordance with the
principles set forth in this Article 7.6.
7.6.4 If a Provisional Suspension is imposed based on an A Sample Adverse
Analytical Finding
and a subsequent B Sample analysis (if requested by the
Athlete or Anti-Doping Organization) does not confirm the A Sample analysis,
then the Athlete shall not be subject to any further Provisional Suspension on
account of a violation of Article 2.1 of the Code (Presence of a Prohibited
Substance
or its Metabolites or Markers). In circumstances where the Athlete (or
the Athlete's team as may be provided in these anti-doping rules) has been
removed from a Competition based on a violation of Article 2.1 and the
subsequent B Sample analysis does not confirm the A Sample finding, if, without
otherwise affecting the Competition, it is still possible for the Athlete or team to
be reinserted, the Athlete or team may continue to take part in the Competition.
7.7 Retirement from Sport
If an Athlete or other Person retires while a results management process is underway,
WBPF or its National Federations conducting the results management process retains
jurisdiction to complete its results management process. If an Athlete or other Person
retires before any results management process has begun and WBPF or its National
Federations
would have had results management jurisdiction over the Athlete or other
Person at the time the Athlete or other Person committed an anti-doping rule violation,
WBPF or its National Federations have jurisdiction to conduct results management.
ARTICLE 8 RIGHT TO A FAIR HEARING
Hearings following WBPF's result management
8.1.1 When it appears, following the Results Management process performed
by WBPF in accordance with Article 7, that these Anti-Doping Rules have been
violated then the case shall be assigned to the WBPF Doping Hearing Panel for
adjudication.
WBPF Anti-Doping Rules
August 2009

8.1.2 Hearings pursuant to this Article shall be completed expeditiously
following the completion of the results management process described in Article
7. Hearings held in connection with Events may be conducted on an expedited
basis. If the Athlete has been imposed a Provisional Suspension as per Article 7.6,
the Athlete has the right to request that the hearing be conducted on an expedited
basis.
8.1.3 The National Federation of the Athlete or other Person alleged to have
violated these Anti-Doping Rules may attend the hearing as an observer.
8.1.4 WBPF shall keep WADA fully apprised as to the status of pending cases
and the result of all hearings.
8.1.5 An Athlete or other Person may forego a hearing by acknowledging the
Anti-Doping Rule violation and accepting Consequences consistent with Articles
9 and 10 as proposed by WBPF. The right to a hearing may be waived either
expressly or by the Athlete's or other Person's failure to challenge WBPF's
assertion that an anti-doping rule violation has occurred within 30 days. Where no
hearing occurs, WBPF shall submit to the Persons described in Article 13.2.3 a
reasoned decision explaining the action taken.
8.1.6 Decisions of the WBPF Doping Hearing Panel may be appealed to the
Court of Arbitration for Sport as provided in Article 13.
Hearings following National Federations result management
8.2.1 When it appears, following the Results Management process performed by
National Federations in accordance with Article 7, that these Anti-Doping Rules
have been violated in connection, the Athlete or other Person involved shall be
brought before a disciplinary panel of the Athlete or other Person's National
Federation
or National Anti-Doping Organization in accordance with the rules of
the National Federation or the National Anti-Doping Organization for a hearing
to adjudicate whether a violation of these Anti-Doping Rules occurred and if so
what Consequences should be imposed.
8.2.2 Hearings pursuant to this Article 8.2 shall be completed expeditiously and
in all cases within three months of the completion of the Results Management
process described in Article 7. Hearings held in connection with Events may be
conducted by an expedited process. If the Athlete has been imposed a Provisional
Suspension
as per Article 7.6, the Athlete has the right to request that the hearing
be conducted on an expedited basis. If the completion of the hearing is delayed
beyond three months, WBPF may elect to bring the case directly before the
WBPF Doping Hearing Panel at the responsibility and at the expense of the
National Federation.
8.2.3 National Federations shall keep WBPF and WADA fully apprised as to the
status of pending cases and the results of all hearings.
WBPF Anti-Doping Rules
August 2009

8.2.4 WBPF and WADA shall have the right to attend hearings as an observer.
8.2.5 The Athlete or other Person may forego a hearing by acknowledging the
violation of these Anti-Doping Rules and accepting Consequences consistent with
Articles 9 and 10 as proposed by the National Federation. The right to a hearing
may be waived either expressly or by the Athlete's or other Person's failure to
challenge the National Federation's assertion that an anti-doping rule violation
has occurred within thirty (30) days. Where no hearing occurs, the National
Federation
shall submit to the Persons described in Article 13.2.3 a reasoned
decision explaining the action taken.
8.2.6 Decisions
Federations Anti-Doping Organizations, whether as the result of a hearing or the Athlete or other Person's acceptance of Consequences, may be appealed as provided in Article 13. Principles for a Fair Hearing
All hearings pursuant to either Article 8.1 or 8.2 shall respect the following principles: • a timely hearing; • fair and impartial hearing panel; • the right to be represented by counsel at the Person's own expense; • the right to be informed in a fair and timely manner of the asserted anti-doping rule • the right to respond to the asserted anti-doping rule violation and resulting Consequences; • the right of each party to present evidence, including the right to call and question witnesses (subject to the hearing panel's discretion to accept testimony by telephone or written submission); • the Person's right to an interpreter at the hearing, with the hearing panel to determine the identity, and responsibility for the cost of the interpreter; and • a timely, written, reasoned decision, specifically including an explanation of the reason(s) for any period of Ineligibility.] * At the discretion of WBPF Anti-doping Hearing panel, and where circumstances
warrant, a hearing may be conducted by written submission so long as the rights of the
athlete or other person as detailed in these Rules are respected.

WBPF Anti-Doping Rules
August 2009

ARTICLE 9 AUTOMATIC DISQUALIFICATION OF INDIVIDUAL RESULTS
An anti-doping rule violation in Individual Sports in connection with an In-Competition test automatically leads to Disqualification of the result obtained in that Competition with all resulting Consequences, including forfeiture of any medals, points and prizes. ARTICLE 10 SANCTIONS ON INDIVIDUALS
Disqualification of Results in Event During which an Anti-Doping Rule
Violation Occurs
An anti-doping rule violation occurring during or in connection with an Event may, upon the decision of the ruling body of the Event, lead to Disqualification of all of the Athlete's individual results obtained in that Event with all consequences, including forfeiture of all medals, points and prizes, except as provided in Article 10.1.1. 10.1.1 If the Athlete establishes that he or she bears No Fault or Negligence for
the violation, the Athlete's individual results in the other Competitions shall not be
Disqualified unless the Athlete's results in Competitions other than the
Competition in which the anti-doping rule violation occurred were likely to have
been affected by the Athlete's anti-doping rule violation.
Ineligibility for Presence, Use or Attempted Use, or Possession of Prohibited
Substances and Prohibited Methods
The period of Ineligibility imposed for a violation of Article 2.1 (Presence of Prohibited Substance or its Metabolites or Markers), Article 2.2 (Use or Attempted Use of Prohibited Substance or Prohibited Method) or Article 2.6 (Possession of Prohibited Substances and Prohibited Methods) shall be as follows, unless the conditions for eliminating or reducing the period of Ineligibility, as provided in Articles 10.4 and 10.5, or the conditions for increasing the period of Ineligibility, as provided in Article 10.6, are met: First violation: Two (2) years' Ineligibility. Ineligibility for Other Anti-Doping Rule Violations
The period of Ineligibility for violations of these Anti-Doping Rules other than as provided in Article 10.2 shall be as follows: 10.3.1 For violations of Article 2.3 (Refusing or Failing to Submit to Sample
collection) or Article 2.5 (Tampering with Doping Control), the Ineligibility
period shall be two (2) years unless the conditions provided in Article 10.5, or the
conditions provided in Article 10.6, are met.
WBPF Anti-Doping Rules
August 2009

10.3.2 For violations of Article 2.7 (Trafficking) or Article 2.8 (Administration or
Attempted Administration of Prohibited Substance or Prohibited Method), the
period of Ineligibility imposed shall be a minimum of four (4) years up to lifetime
Ineligibility unless the conditions provided in Article 10.5 are met. An anti-
doping rule violation involving a Minor shall be considered a particularly serious
violation, and, if committed by Athlete Support Personnel for violations other
than Specified Substances referenced in Article 4.2.2 shall result in lifetime
Ineligibility for Athlete Support Personnel. In addition, significant violations of
Articles 2.7 or 2.8 which may also violate non-sporting laws and regulations, shall
be reported to the competent administrative, professional or judicial authorities.
10.3.3 For violations of Article 2.4 (Whereabouts Filing Failures and/ or Missed
Tests), the period of Ineligibility shall be at a minimum one (1) year and at a
maximum two (2) years based on the Athlete's degree of fault.
10.4 Elimination or Reduction of the Period of Ineligibility for Specified Substances
under Specific Circumstances

Where an Athlete or other Person can establish how a Specified Substance entered his or her body or came into his or her Possession and that such Specified Substance was not intended to enhance the Athlete's sport performance or mask the Use of a performance-enhancing substance, the period of Ineligibility found in Article 10.2 shall be replaced with the following: First violation: At a minimum, a reprimand and no period of Ineligibility from future Events, and at a maximum, two (2) years of Ineligibility. To justify any elimination or reduction, the Athlete or other Person must produce corroborating evidence in addition to his or her word which establishes to the comfortable satisfaction of the hearing panel the absence of an intent to enhance sport performance or mask the Use of a performance enhancing substance. The Athlete's or other Person's degree of fault shall be the criterion considered in assessing any reduction of the period of Ineligibility. Elimination or Reduction of Period of Ineligibility Based on Exceptional
10.5.1 No Fault or Negligence
If an Athlete establishes in an individual case that he or she bears No Fault or Negligence, the otherwise applicable period of Ineligibility shall be eliminated. When a Prohibited Substance or its Markers or Metabolites is detected in an WBPF Anti-Doping Rules
August 2009

Athlete's Sample in violation of Article 2.1 (Presence of Prohibited Substance), the Athlete must also establish how the Prohibited Substance entered his or her system in order to have the period of Ineligibility eliminated. In the event this Article is applied and the period of Ineligibility otherwise applicable is eliminated, the anti-doping rule violation shall not be considered a violation for the limited purpose of determining the period of Ineligibility for multiple violations under Article 10.7. 10.5.2 No Significant Fault or Negligence
If an Athlete or other Person establishes in an individual case that he or she bears No Significant Fault or Negligence, then the otherwise applicable period of Ineligibility may be reduced, but the reduced period of Ineligibility may not be less than one-half of the period of Ineligibility otherwise applicable. If the otherwise applicable period of Ineligibility is a lifetime, the reduced period under this Article may be no less than eight (8) years. When a Prohibited Substance or its Markers or Metabolites is detected in an Athlete's Sample in violation of Article 2.1 (Presence of a Prohibited Substance or its Metabolites or Markers), the Athlete must also establish how the Prohibited Substance entered his or her system in order to have the period of Ineligibility reduced. 10.5.3 Substantial Assistance in Discovering or Establishing Anti-Doping Rule
Violations
WBPF or its National Federations may, prior to a final appellate decision under Article 13 or the expiration of the time to appeal, suspend a part of the period of Ineligibility imposed in an individual case where the Athlete or other Person has provided Substantial Assistance to an Anti-Doping Organization, criminal authority or professional disciplinary body which results in the Anti-Doping Organization discovering or establishing an anti-doping rule violation by another Person or which results in a criminal or disciplinary body discovering or establishing a criminal offense or the breach of professional rules by another Person. After a final appellate decision under Article 13 or the expiration of time to appeal, WBPF may only suspend a part of the otherwise applicable period of Ineligibility with the approval of WADA. After a final appellate decision under Article 13 or the expiration of time to appeal, National Federations may only suspend a part of the otherwise applicable period of Ineligibility with the approval of WBPF and WADA. The extent to which the otherwise applicable period of Ineligibility may be suspended shall be based on the seriousness of the anti-doping rule violation committed by the Athlete or other Person and the significance of the Substantial Assistance provided by the Athlete or other Person to the effort to eliminate doping in sport. No more than three-quarters of the otherwise applicable period of Ineligibility may be suspended. If the otherwise applicable period of Ineligibility is a lifetime, the non-suspended period under this Article must be no less than eight (8) years. If WBPF or its National Federations WBPF Anti-Doping Rules
August 2009

suspend any part of the otherwise applicable period of Ineligibility under this Article, they shall promptly provide a written justification for its decision to each Anti-Doping Organization having a right to appeal the decision. If WBPF or its National Federations subsequently reinstate any part of the suspended period of Ineligibility because the Athlete or other Person has failed to provide the Substantial Assistance which was anticipated, the Athlete or other Person may appeal the reinstatement pursuant to Article 13.2. 10.5.4 Admission of an Anti-Doping Rule Violation in the Absence of Other
Evidence
Where an Athlete or other Person voluntarily admits the commission of an anti-
doping rule violation before having received notice of a Sample collection which
could establish an anti-doping rule violation (or, in the case of an anti-doping rule
violation other than Article 2.1, before receiving first notice of the admitted
violation pursuant to Article 7) and that admission is the only reliable evidence of
the violation at the time of admission, then the period of Ineligibility may be
reduced, but not below one-half of the period of Ineligibility otherwise applicable.
10.5.5 Where an Athlete or Other Person Establishes Entitlement to Reduction in
Sanction under More than One Provision of this Article
Before applying any reduction or suspension under Articles 10.5.2, 10.5.3 or
10.5.4, the otherwise applicable period of Ineligibility shall be determined in
accordance with Articles 10.2, 10.3, 10.4 and 10.6. If the Athlete or other Person
establishes entitlement to a reduction or suspension of the period of Ineligibility
under two or more of Articles 10.5.2, 10.5.3 or 10.5.4, then the period of
Ineligibility may be reduced or suspended, but not below one-fourth of the
otherwise applicable period of Ineligibility.
10.6 Aggravating Circumstances Which May Increase the Period of Ineligibility
If WBPF or its National Federations establishes in an individual case involving an anti-doping rule violation other than violations under Articles 2.7 (Trafficking or Attempted Trafficking) and 2.8 (Administration or Attempted Administration) that aggravating circumstances are present which justify the imposition of a period of Ineligibility greater than the standard sanction, then the period of Ineligibility otherwise applicable shall be increased up to a maximum of four (4) years unless the Athlete or other Person can prove to the comfortable satisfaction of the hearing panel that he did not knowingly commit the anti-doping rule violation. WBPF Anti-Doping Rules
August 2009

An Athlete or other Person can avoid the application of this Article by admitting the anti-doping rule violation as asserted promptly after being confronted with the anti-doping rule violation by WBPF or its National Federations. 10.7 Multiple Violations

10.7.1 Second Anti-Doping Rule Violation
For an Athlete's or other Person's first anti-doping rule violation, the period of
Ineligibility is set forth in Articles 10.2 and 10.3 (subject to elimination, reduction
or suspension under Articles 10.4 or 10.5, or to an increase under Article 10.6).
For a second anti-doping rule violation the period of Ineligibility shall be within
the range set forth in the table below.
Second Violation First Violation Definitions for purposes of the second anti-doping rule violation table:
RS (Reduced sanction for Specified Substance under Article 10.4): The anti-
doping rule violation was or should be sanctioned by a reduced sanction under
Article 10.4 because it involved a Specified Substance and the other conditions
under Article 10.4 were met.
FFMT (Filing Failures and/or Missed Tests): The anti-doping rule violation was
or should be sanctioned under Article 10.3.3 (Filing Failures and/or Missed
Tests).
NSF (Reduced sanction for No Significant Fault or Negligence): The anti-doping
rule violation was or should be sanctioned by a reduced sanction under Article
10.5.2 because No Significant Fault or Negligence under Article 10.5.2 was
proved by the Athlete.
St (Standard sanction under Articles 10.2 or 10.3.1): The anti-doping rule
violation was or should be sanctioned by the standard sanction of two (2) years
under Articles 10.2 or 10.3.1.
WBPF Anti-Doping Rules
August 2009

AS (Aggravated sanction): The anti-doping rule violation was or should be
sanctioned by an aggravated sanction under Article 10.6 because the Anti-Doping
Organization established the conditions set forth under Article 10.6.
TRA (Trafficking or Attempted Trafficking and administration or Attempted
administration): The anti-doping rule violation was or should be sanctioned by a
sanction under Article 10.3.2.
10.7.2 Application of Articles 10.5.3 and 10.5.4 to Second Anti-Doping Rule
Violation
Where an Athlete or other Person who commits a second anti-doping rule
violation establishes entitlement to suspension or reduction of a portion of the
period of Ineligibility under Article 10.5.3 or Article 10.5.4, the hearing panel
shall first determine the otherwise applicable period of Ineligibility within the
range established in the table in Article 10.7.1, and then apply the appropriate
suspension or reduction of the period of Ineligibility. The remaining period of
Ineligibility, WBPFter applying any suspension or reduction under Articles 10.5.3
and 10.5.4, must be at least one-fourth of the otherwise applicable period of
Ineligibility.
10.7.3 Third Anti-Doping Rule Violation
A third anti-doping rule violation will always result in a lifetime period of
Ineligibility, except if the third violation fulfills the condition for elimination or
reduction of the period of Ineligibility under Article 10.4 or involves a violation of
Article 2.4 (Filing Failures and/or and Missed Tests). In these particular cases, the
period of Ineligibility shall be from eight (8) years to life ban.
10.7.4 Additional Rules for Certain Potential Multiple Violations
For purposes of imposing sanctions under Article 10.7, an anti-doping rule violation will only be considered a second violation if WBPF (or its National Federation) can establish that the Athlete or other Person committed the second anti-doping rule violation after the Athlete or other Person received notice pursuant to Article 7 (Results Management), or after WBPF (or its National Federation) made reasonable efforts to give notice, of the first anti-doping rule violation; if WBPF (or its National Federation) cannot establish this, the violations shall be considered together as one single first violation, and the sanction imposed shall be based on the violation that carries the more severe sanction; however, the occurrence of multiple violations may be considered as a factor in determining aggravating circumstances (Article 10.6). WBPF Anti-Doping Rules
August 2009

If, after the resolution of a first anti-doping rule violation, WBPF (or its National Federations) discovers facts involving an anti-doping rule violation by the Athlete or other Person which occurred prior to notification regarding the first violation, then WBPF (or its National Federations) shall impose an additional sanction based on the sanction that could have been imposed if the two violations would have been adjudicated at the same time. Results in all Competitions dating back to the earlier anti-doping rule violation will be Disqualified as provided in Article 10.8. To avoid the possibility of a finding of Aggravating Circumstances (Article 10.6) on account of the earlier-in-time but later-discovered violation, the Athlete or other Person must voluntarily admit the earlier anti-doping rule violation on a timely basis after notice of the violation for which he or she is first charged. The same rule shall also apply when WBPF (or its National Federations) discovers facts involving another prior violation after the resolution of a second anti-doping rule violation. 10.7.5 Multiple Anti-Doping Rule Violations during an Eight-Year Period
For purposes of Article 10.7, each anti-doping rule violation must take place within
the same eight (8) year period in order to be considered multiple violations.
10.8 Disqualification of Results in Competitions Subsequent to Sample Collection or
Commission of an Anti-Doping Rule Violation

In addition to the automatic Disqualification of the results in the Competition which produced the positive Sample under Article 9 (Automatic Disqualification of Individual Results), all other competitive results obtained from the date a positive Sample was collected (whether In-Competition or Out-of-Competition), or other anti-doping rule violation occurred, through the commencement of any Provisional Suspension or Ineligibility period, shall, unless fairness requires otherwise, be Disqualified with all of the resulting Consequences including forfeiture of any medals, points and prizes. 10.8.1 As a condition of regaining eligibility after being found to have committed
an anti-doping rule violation, the Athlete must first repay all prize money forfeited
under this Article.
10.8.2 Allocation of Forfeited Prize Money.
Forfeited prize money shall be reallocated to other Athletes. Commencement of Ineligibility Period
Except as provided below, the period of Ineligibility shall start on the date of the hearing decision providing for Ineligibility or, if the hearing is waived, on the date Ineligibility is WBPF Anti-Doping Rules
August 2009

accepted or otherwise imposed. Any period of Provisional Suspension (whether imposed or voluntarily accepted) shall be credited against the total period of Ineligibility imposed. 10.9.1 Delays Not Attributable to the Athlete or other Person
Where there have been substantial delays in the hearing process or other aspects of Doping Control not attributable to the Athlete or other Person, the WBPF or Anti-Doping Organization imposing the sanction may start the period of Ineligibility at an earlier date commencing as early as the date of Sample collection or the date on which another anti-doping rule violation last occurred.
10.9.2
Timely Admission
Where the Athlete promptly (which, in all events, means before the Athlete
competes again) admits the anti-doping rule violation after being confronted with
the anti-doping rule violation by WBPF or its National Federations, the period of
Ineligibility may start as early as the date of Sample collection or the date on
which another anti-doping rule violation last occurred. In each case, however,
where this Article is applied, the Athlete or other Person shall serve at least one-
half of the period of Ineligibility going forward from the date the Athlete or other
Person accepted the imposition of a sanction, the date of a hearing decision
imposing a sanction, or the date the sanction is otherwise imposed.
10.9.3 If a Provisional Suspension is imposed and respected by the Athlete, then
the Athlete shall receive a credit for such period of Provisional Suspension against
any period of Ineligibility which may ultimately be imposed.
10.9.4 If an Athlete voluntarily accepts a Provisional Suspension in writing from
WBPF or its National Federations and thereafter refrains from competing, the
Athlete shall receive a credit for such period of voluntary Provisional Suspension
against any period of Ineligibility which may ultimately be imposed. A copy of
the Athlete's voluntary acceptance of a Provisional Suspension shall be provided
promptly to each party entitled to receive notice of a potential anti-doping rule
violation under Article 14.1.
10.9.5 No credit against a period of Ineligibility shall be given for any time period
before the effective date of the Provisional Suspension or voluntary Provisional
Suspension
regardless of whether the Athlete elected not to compete or was
suspended by his or her team.
WBPF Anti-Doping Rules
August 2009

10.10 Status During Ineligibility
10.10.1 Prohibition against Participation during Ineligibility
No Athlete or other Person who has been declared Ineligible may, during the period of Ineligibility, participate in any capacity in a Competition or activity (other than authorized anti-doping education or rehabilitation programs) authorized or organized by WBPF or any National Federation or a club or other member organization of WBPF or any National Federation, or in Competitions authorized or organized by any professional league or any international or national level Event organization. An Athlete or other Person subject to a period of Ineligibility longer than four years may, after completing four years of the period of Ineligibility, participate in local sport events in a sport other than the sport in which the Athlete or other Person committed the anti-doping rule violation, but only so long as the local sport event is not at a level that could otherwise qualify such Athlete or other Person directly or indirectly to compete in (or accumulate points toward) a national championship or International Event. An Athlete or other Person subject to a period of Ineligibility shall remain subject to Testing. 10.10.2 Violation of the Prohibition of Participation during Ineligibility

Where an Athlete or other Person who has been declared Ineligible violates the
prohibition against participation during Ineligibility described in Article 10.10.1, the
results of such participation shall be Disqualified and the period of Ineligibility
which was originally imposed shall start over again as of the date of the violation.
The new period of Ineligibility may be reduced under Article 10.5.2 if the Athlete or
other Person establishes he or she bears No Significant Fault or Negligence for
violating the prohibition against participation. The determination of whether an
Athlete or other Person has violated the prohibition against participation, and
whether a reduction under Article 10.5.2 is appropriate, shall be made by WBPF or
its National Federations
.

10.10.3
Withholding of Financial Support during Ineligibility
In addition, for any anti-doping rule violation not involving a reduced sanction for
Specified Substances as described in Article 10.4, some or all sport-related financial
support or other sport-related benefits received by such Person will be withheld by
WBPF and its National Federations.
WBPF Anti-Doping Rules
August 2009

10.11 Reinstatement Testing
As a condition to regaining eligibility at the end of a specified period of Ineligibility, an
Athlete must, during any period of Provisional Suspension or Ineligibility, make him or
herself available for Out-of-Competition Testing by WBPF, the applicable National
Federation
, and any other Anti-Doping Organization having Testing jurisdiction, and must,
if requested, provide current and accurate whereabouts information. If an Athlete subject to
a period of Ineligibility retires from sport and is removed from Out-of-Competition Testing
pools and later seeks reinstatement, the Athlete shall not be eligible for reinstatement until
the Athlete has notified WBPF and the applicable National Federation and has been subject
to Out-of-Competition Testing for a period of time equal to the [longer of (a) the period set
forth in Article 5.6 and (b)] period of Ineligibility remaining as of the date the Athlete had
retired. During such remaining period of Ineligibility, a minimum of 2 tests must be
conducted on the Athlete with at least three months between each test. The National
Federation
shall be responsible for conducting the necessary tests, but tests by any Anti-
Doping Organization
may be used to satisfy the requirement. The results of such tests shall
be reported to WBPF. In addition, immediately prior to the end of the period of Ineligibility,
an Athlete must undergo Testing by WBPF or its National Federations for the Prohibited
Substance
s and Methods that are prohibited in Out-of-Competition Testing. Once the period
of an Athlete's Ineligibility has expired, and the Athlete has fulfilled the conditions of
reinstatement, then the Athlete will become automatically re-eligible and no application by
the Athlete or by the Athlete's National Federation will then be necessary.
10. 12 Imposition of Financial Sanctions
Anti-doping Organizations may, in their own rules, provide for financial sanctions on account of anti-doping rule violations. However, no financial sanction may be considered a basis for reducing the period of ineligibility or other sanction which would otherwise be applicable under the Code. ARTICLE 11 CONSEQUENCES TO TEAMS
If a member of a team is found to have committed a violation during an event where a team ranking is based on the addition of individual results (e.g. Best National Team World), the results of the Athlete committing the violation will be subtracted from team result. If more than two members of a team is found to have committing a violation during an event where a team ranking is based on the addition of individual results (e.g. Best National Team Award), the results of the entire team will be declared invalid. Event Ruling Body May Establish Stricter Consequences for Team Sports.
WBPF Anti-Doping Rules
August 2009

The ruling body for an Event may elect to establish rules for the Event which impose Consequences for Team Sports stricter than those in Article 11.2 for purposes of the Event. ARTICLE 12
SANCTIONS AND COSTS ASSESSED AGAINST NATIONAL
FEDERATION
S
[NOTE : Under this article, IF may integrate provisions for imposing sanctions on its National Federations or any other sporting body over which IF has authority; article 12.1 derivates from article 20.3.8 of the Code] The WBPF Executive Council has the authority to withhold some or all funding or other non financial support to National Federations that are not in compliance with these Anti-Doping Rules. Affiliated Federations shall be obligated to reimburse WBPF for all costs (including but not limited to laboratory fees, hearing expenses and travel) related to a violation of these Anti-Doping Rules committed by an Athlete or other Person affiliated with that Federation. WBPF may elect to take additional disciplinary action against National Federations with respect to recognition, the eligibility of its officials and athletes to participate in International Events and fines based on the following: 12.3.1 Four or more violations of these Anti-Doping Rules (other than violations
involving Articles 2.4 and 10.3) are committed by Athletes or other Persons
affiliated with a National Federation within a 12-month period in testing conducted
by WBPF or Anti-Doping Organizations other than the National Federation or its
National Anti-Doping Organization. [In such event the WBPF may in its discretion
elect to: (a) ban all officials from that National Federation for participation in any
WBPF activities for a period of up to two years and/or (b) fine the National
Federation
in an amount as determined from time to time by the WBPF Executive
Council. (For purposes of this Rule, any fine paid pursuant to Rule 12.3.2 shall be
credited against any fine assessed.)
12.3.1.1 If four or more violations of these Anti-Doping Rules (other than
violations involving Articles 2.4 and 10.3) are committed in addition to the
violations described in Article 12.3.1 by Athletes or other Persons affiliated
with a National Federation within a 12-month period in testing conducted by
WBPF or Anti-Doping Organizations other than the National Federation or
its National Anti-Doping Organization, then the WBPF may suspend that
National Federation's membership for a period of up to 4 years.
12.3.2 More than one Athlete or other Person from a National Federation commits
an Anti-Doping Rule violation during an International Event. [In such event IF may
fine that National Federation in an amount up to as determined from time to time by
the WBPF Executive Council.
WBPF Anti-Doping Rules
August 2009

12.3.3 A National Federation has failed to make diligent efforts to keep WBPF
informed about an Athlete's whereabouts after receiving a request for that
information from WBPF. In such event WBPF may fine the National Federation in
an amount up to as determined from time to time by the WBPF Executive Council
per Athlete in addition to all of WBPF costs incurred in Testing that National
Federation's Athletes
.
ARTICLE 13 APPEALS
Decisions Subject to Appeal
Decisions made under these Anti-Doping Rules may be appealed as set forth below in Article 13.2 through 13.4 or as otherwise provided in these Anti-Doping Rules. Such decisions shall remain in effect while under appeal unless the appellate body orders otherwise. Before an appeal is commenced, any post-decision review provided in these rules or in the rules of the Anti-Doping Organization conducting the hearing process as per article 8 must be exhausted (except as provided in Article 13.1.1). 13.1.1 WADA Not Required to Exhaust Internal Remedies
Where WADA has a right to appeal under Article 13 and no other party has appealed a final decision within the WBPF or its National Federation's process, WADA may appeal such decision directly to CAS without having to exhaust other remedies in the WBPF or its National Federation's process. Appeals from Decisions Regarding Anti-Doping Rule Violations, Consequences,
and Provisional Suspensions
A decision that an anti-doping rule violation was committed, a decision imposing Consequences for an anti-doping rule violation, or a decision that no anti-doping rule violation was committed; a decision that an anti-doping rule violation proceeding cannot go forward for procedural reasons (including, for example, prescription); a decision under Article 10.10.2 (Violation of the Prohibition of Participation during Ineligibility); a decision that the WBPF or its National Federation lacks jurisdiction to rule on an alleged anti-doping rule violation or its Consequences; a decision by an Anti-Doping Organization not to bring forward an Adverse Analytical Finding or an Atypical Finding as an anti-doping rule violation, or a decision not to go forward with an anti-doping rule violation after an investigation under Article 7.4; and a decision to impose a Provisional Suspension as a result of a Provisional Hearing or in violation of Article 7.5 may be appealed exclusively as provided in this Article 13.2. 13.2.1 Appeals Involving International-Level Athletes
WBPF Anti-Doping Rules
August 2009

In cases arising from participation in an International Event or in cases involving International-Level Athletes, the decision may be appealed exclusively to CAS in accordance with the provisions applicable before such court.
To mean decision of the final appeal open to the athlete or other person within
the WBPF, including Article 13 of these Rules and Part 6 of the WBPF
Constitution.
13.2.2 Appeals Involving National-Level Athletes
In cases involving national-level Athletes as defined by each National Anti-Doping Organization who do not have a right to appeal under Article 13.2.1, the decision may be appealed to an independent and impartial body in accordance with rules established by the National Anti-Doping Organization. If the National Anti-Doping Organization has not established such a body, the decision may be appealed to CAS in accordance with the provisions applicable before such court. 13.2.3 Persons Entitled to Appeal
In cases under Article 13.2.1, the following parties shall have the right to appeal to CAS: (a) the Athlete or other Person who is the subject of the decision being appealed; (b) the other party to the case in which the decision was rendered; (c) IF/WBPF; (d) the National Anti-Doping Organization of the Person's country of residence or countries where the Person is a national or license holder; (e) the International Olympic Committee or International Paralympic Committee, as applicable, where the decision may have an effect in relation to the Olympic Games or Paralympic Games, including decisions affecting eligibility for the Olympic Games or Paralympic Games; and (f) WADA. In cases under Article 13.2.2, the parties having the right to appeal to the national-level reviewing body shall be as provided in the National Anti-Doping Organization's rules but, at a minimum, shall include the following parties: (a) the Athlete or other Person who is the subject of the decision being appealed; (b) the other party to the case in which the decision was rendered; (c) IF/ WBPF; (d) the National Anti-Doping Organization of the Person's country of residence; and (e) WADA. For cases under Article 13.2.2, WADA and the International Federation shall also have the right to appeal to CAS with respect to the decision of the national-level reviewing body. Any party filing an appeal shall be entitled to assistance from CAS to obtain all relevant information from the Anti-Doping Organization whose decision is being appealed and the information shall be provided if CAS so directs. WBPF Anti-Doping Rules
August 2009

Notwithstanding any other provision herein, the only Person who may appeal from a Provisional Suspension is the Athlete or other Person upon whom the Provisional Suspension is imposed. Failure to Render a Timely Decision by WBPF and its National Federations
Where, in a particular case, WBPF or its National Federations fail to render a decision with respect to whether an anti-doping rule violation was committed within a reasonable deadline set by WADA, WADA may elect to appeal directly to CAS as if WBPF IF or its National Federations had rendered a decision finding no anti-doping rule violation. If the CAS hearing panel determines that an anti-doping rule violation was committed and that WADA acted reasonably in electing to appeal directly to CAS, then WADA's costs and attorneys fees in prosecuting the appeal shall be reimbursed to WADA by WBPF or its National Federations. Appeals from Decisions Granting or Denying a Therapeutic Use Exemption
Decisions by WADA reversing the grant or denial of a TUE may be appealed exclusively to CAS by the Athlete or the Anti-Doping Organization whose decision was reversed. Decisions by Anti-Doping Organizations other than WADA denying TUE's, which are not reversed by WADA, may be appealed by International-Level Athletes to CAS and by other Athletes to the national level reviewing body described in Article 13.2.2. If the national level reviewing body reverses the decision to deny a TUE, that decision may be appealed to CAS by WADA. When WBPF, National Anti-Doping Organizations or other bodies designated by National Federations fail to take action on a properly submitted TUE application within a reasonable time, their failure to decide may be considered a denial for purposes of the appeal rights provided in this Article. Appeal from Decisions Pursuant to Article 12
Decisions by WBPF pursuant to Article 12 may be appealed exclusively to CAS by the National Federation. Time for Filing Appeals
The time to file an appeal to CAS shall be twenty-one (21) days from the date of receipt of the decision by the appealing party. The above notwithstanding, the following shall apply in connection with appeals filed by a party entitled to appeal but which was not a party to the proceedings having lead to the decision subject to appeal: a) Within ten (10) days from notice of the decision, such party/ies shall have the right to request from the body having issued the decision a copy of the file on which such body relied; WBPF Anti-Doping Rules
August 2009

b) If such a request is made within the ten-day period, then the party making such request shall have twenty-one (21) days from receipt of the file to file an appeal to CAS. The above notwithstanding, the filing deadline for an appeal or intervention filed by WADA shall be the later of: (a) Twenty-one (21) days after the last day on which any other party in the case could have appealed, or (b) Twenty-one (21) days after WADA's receipt of the complete file relating to the decision. ARTICLE 14
REPORTING AND RECOGNITION
Notice, Confidentiality and Reporting
Notice to Athletes and Other Persons. Notice to Athletes or other Persons shall occur as provided under Article 7. Notice to an Athlete or other Person who is a member of a National Federation may be accomplished by delivery of the notice to the National Federation. 14.1.2 Notice to National Anti-Doping Organizations, WBPF and WADA. Notice to National Anti-Doping Organizations, WBPF and WADA shall occur as provided under Article 7. 14.1.3 Content of Notification. Notification to the Athlete's National Anti-Doping Organization, WBPF and WADA according to Article 7 shall include: the Athlete's name, country, sport and discipline within the sport, the Athlete's competitive level, whether the test was In-Competition or Out-of-Competition, the date of Sample collection and the analytical result reported by the laboratory. The same Persons and Anti-Doping Organizations shall be regularly updated on the status and findings of any review or proceedings conducted pursuant to Articles 7 (Results Management), 8 (Right to a Fair Hearing) or 13 (Appeals) and shall be provided with a prompt written reasoned explanation or decision explaining the resolution of the matter. Confidentiality. WBPF Anti-Doping Rules
August 2009

The recipient organizations shall not disclose this information beyond those Persons with a need to know (which would include the appropriate personnel at the applicable National Olympic Committee, National Federation, and team in a Team Sport) until the Anti-Doping Organization with results management responsibility has made public disclosure or has failed to make public disclosure as required in Article 14.2 below. Public Disclosure.

14.2.1 The identity of any Athlete or other Person who is asserted by WBPF or its
National Federations to have committed an anti-doping rule violation, may be publicly
disclose
d by WBPF or its National Federations only after notice has been provided to the
Athlete or other Person in accordance with Articles 7.1, 7.2 or 7.4, and to the applicable
Anti-Doping Organizations in accordance with Article 14.1.2.
14.2.2 No later than twenty (20) days after it has been determined in a hearing in
accordance with Article 8 that an anti-doping rule violation has occurred, or such hearing
has been waived, or the assertion of an anti-doping rule violation has not been timely
challenged, WBPF or its National Federations must publicly report the disposition of the
anti-doping matter including the sport, the anti-doping rule violated, the name of the
Athlete or other Person committing the violation, the Prohibited Substance or Prohibited
Method
involved and the Consequences imposed. WBPF or its National Federations
must also publicly report within twenty (20) days appeal decisions concerning anti-
doping rule violations. WBPF or its National Federations shall also, within the time
period for publication, send all hearing and appeal decisions to WADA.
14.2.3 In any case where it is determined, after a hearing or appeal, that the Athlete or
other Person did not commit an anti-doping rule violation, the decision may be disclosed
publicly only with the consent of the Athlete or other Person who is the subject of the
decision. WBPF and its National Federations shall use reasonable efforts to obtain such
consent, and if consent is obtained, shall publicly disclose the decision in its entirety or in
such redacted form as the Athlete or other Person may approve.
14.2.4 For purposes of Article 14.2, publication shall be accomplished at a minimum by
placing the required information on the WBPF or its National Federations' Web site and
leaving the information up for at least one (1) year.
14.2.5 Neither WBPF, nor its National Federation, or official of either, shall publicly
comment on the specific facts of a pending case (as opposed to general description of
process and science) except in response to public comments attributed to the Athlete,
other Person or their representatives.
14.3
Athlete Whereabouts Information.
As further provided in the International Standard for Testing, Athletes who have been identified by WBPF or its National Federations for inclusion in a Registered Testing WBPF Anti-Doping Rules
August 2009

Pool shall provide accurate, current location information. WBPF and National Anti-
Doping Organization
s shall coordinate the identification of Athletes and the collecting of
current location information and shall submit these to WADA. This information will be
accessible, through ADAMS where reasonably feasible, to other Anti-Doping
Organization
s having jurisdiction to test the Athlete. This information shall be
maintained in strict confidence at all times; shall be used exclusively for purposes of
planning, coordinating or conducting Testing; and shall be destroyed after it is no longer
relevant for these purposes.
14.4
Statistical Reporting.

WBPF or its National Federations shall, at least annually, publish publicly a general
statistical report of their Doping Control activities with a copy provided to WADA.
WBPF or its National Federations may also publish reports showing the name of each
Athlete tested and the date of each Testing.
14.5
Doping Control Information Clearinghouse.

WADA shall act as a central clearinghouse for Doping Control Testing data and results for
International-Level Athletes and national-level Athletes who have been included in their
National Anti-Doping Organization's Registered Testing Pool. To facilitate coordinated
test distribution planning and to avoid unnecessary duplication in Testing by the various
Anti-Doping Organizations, WBPF or its National Federations shall report all In-
Competition
and Out-of-Competition tests on such Athletes to the WADA clearinghouse
as soon as possible after such tests have been conducted. This information will be made
accessible to the Athlete, the Athlete's National Federation, National Olympic Committee
or National Paralympic Committee, National Anti-Doping Organization, WBPF, and the
International Olympic Committee or International Paralympic Committee.
To enable it to serve as a clearinghouse for Doping Control Testing data, WADA has
developed a database management tool, ADAMS that reflects emerging data privacy
principles. Private information regarding an Athlete, Athlete Support Personnel, or others
involved in anti-doping activities shall be maintained by WADA, which is supervised by
Canadian privacy authorities, in strict confidence and in accordance with the
International Standard for the protection of privacy.
14.6
Data Privacy.
When performing obligations under these rules, WBPF or its National Federations may collect, store, process or disclose personal information relating to Athletes and third parties. WBPF or its National Federations shall ensure that they comply with applicable data protection and privacy laws with respect to their handling of such information, as well as the International Standard for the protection of privacy that WADA shall adopt to ensure Athletes and non-athletes are fully informed of and, where necessary, agree to the handling of their personal information in connection with anti-doping activities arising under the Code and these anti-doping rules. WBPF Anti-Doping Rules
August 2009

ARTICLE 15 MUTUAL RECOGNITION
15.1 Subject to the right to appeal provided in Article 13, Testing, TUE's and hearing results or other final adjudications of any National Federation or Signatory which are consistent with the Code and are within the National Federation or Signatory's authority, shall be recognized and respected by WBPF and all National Federations. 15.2 WBPF and its National Federations shall recognize the same actions of other bodies which have not accepted the Code if the rules of those bodies are otherwise consistent with the Code. Subject to the right to appeal provided in Article 13, any decision of WBPF regarding a violation of these Anti-Doping Rules shall be recognized by all National Federations, which shall take all necessary action to render such decision effective. ARTICLE 16 INCORPORATION OF IF ANTI-DOPING RULES
All National Federations shall comply with these Anti-Doping Rules. These Anti-Doping Rules shall also be incorporated either directly or by reference into each National Federations Rules. All National Federations shall include in their regulations the procedural rules necessary to effectively implement these Anti-Doping Rules. ARTICLE 17 STATUTE OF LIMITATIONS
No action may be commenced against an Athlete or other Person for an anti-doping rule violation contained in these Anti-Doping Rules unless such action is commenced within eight (8) years from the date the violation is asserted to have occurred. ARTICLE 18
WBPF COMPLIANCE REPORTS TO WADA
The WBPF will report to WADA on the WBPF's compliance with the Code every second year and shall explain reasons for any noncompliance. ARTICLE 19
AMENDMENT AND INTERPRETATION OF ANTI-DOPING
RULES

These Anti-Doping Rules may be amended from time to time by WBPF. These Anti-Doping Rules shall be interpreted as an independent and autonomous text and not by reference to existing law or statutes, except as provided in Article 19.5. The headings used for the various Parts and Articles of these Anti-Doping Rules are for convenience only and shall not be deemed part of the substance of these Anti-Doping Rules or to affect in any way the language of the provisions to which they refer. WBPF Anti-Doping Rules
August 2009

The INTRODUCTION, the APPENDIX I, DEFINITIONS and the International Standards issued by WADA shall be considered integral parts of these Anti-Doping Rules. These Anti-Doping Rules have been adopted pursuant to the applicable provisions of the Code and shall be interpreted in a manner that is consistent with applicable provisions of the Code. The comments annotating various provisions of the Code and these Anti-Doping Rules should be used to interpret these Anti-Doping Rules. These Anti-Doping Rules have come into full force and effect on 1 January 2009 (the "Effective Date"). They shall not apply retrospectively to matters pending before the Effective Date; provided, however, that: 19.7.1 With respect to any anti-doping rule violation case which is pending as of
the Effective Date and any anti-doping rule violation case brought after the Effective
Date based on an anti-doping rule violation which occurred prior to the Effective
Date, the case shall be governed by the substantive anti-doping rules in effect at the
time the alleged anti-doping rule violation occurred unless the panel hearing the case
determines the principle of "lex mitior" appropriately applies under the
circumstances of the case.
19.7.2 Any Article 2.4 whereabouts violation (whether a filing failure or a missed
test) declared by WBPF under rules in force prior to the Effective Date that has not
expired prior to the Effective Date and that would qualify as a whereabouts violation
under Article 11 of the International Standard for Testing shall be carried forward
and may be relied upon, prior to expiry, in accordance with the International
Standards
for Testing.
19.7.3 With respect to cases where a final decision finding an anti-doping rule
violation has been rendered prior to the Effective Date, but the Athlete or other
Person is still serving the period of Ineligibility as of the Effective Date, the
Athlete or other Person may apply to the Anti-Doping Organization which had
results management responsibility for the anti-doping rule violation to consider a
reduction in the period of Ineligibility in light of these anti-doping rules. Such
application must be made before the period of Ineligibility has expired. The
decision rendered may be appealed pursuant to Article 13.2. These anti-doping
rules shall have no application to any anti-doping rule violation case where a final
decision finding an anti-doping rule violation has been rendered and the period of
Ineligibility has expired.
19.7.4 Subject always to Article 10.7.5, anti-doping rule violations committed
under rules in force prior to the Effective Date shall be taken into account as prior
offences for purposes of determining sanctions under Article 10.7. Where such pre-
Effective Date anti-doping rule violation involved a substance that would be treated
as a Specified Substance under these Anti-Doping Rules, for which a period of
WBPF Anti-Doping Rules
August 2009

Ineligibility of less than two years was imposed, such violation shall be considered a Reduced Sanction violation for purposes of Article 10.7.1.
ARTICLE 20: ADDITIONAL ROLES AND RESPONSIBILITIES OF ATHLETES AND
OTHER PERSONS

Roles and Responsibilities of Athletes. To be knowledgeable of and comply with these anti-doping rules To be available for Sample collection. To take responsibility, in the context of anti-doping, for what they ingest and use. 20.1.4 To inform medical personnel of their obligation not to Use Prohibited Substances and Prohibited Methods and to take responsibility to make sure that any medical treatment received does not violate these anti-doping rules. Roles and Responsibilities of Athlete Support Personnel To be knowledgeable of and comply with these anti-doping rules. To cooperate with the Athlete Testing program. To use their influence on Athlete values and behavior to foster anti- doping attitudes. WBPF Anti-Doping Rules
August 2009

APPENDIX 1 - DEFINITIONS

ABPF: Asian Body Building and Physique Sports Federation.
ADAMS. The Anti-Doping Administration and Management System is a Web-based database
management tool for data entry, storage, sharing, and reporting designed to assist stakeholders
and WADA in their anti-doping operations in conjunction with data protection legislation.
Adverse Analytical Finding
. A report from a laboratory or other WADA-approved Testing entity
that, consistent with the International Standard for Laboratories and related Technical
Documents, identifies in a Sample the presence of a Prohibited Substance or its Metabolites or
Markers (including elevated quantities of endogenous substances) or evidence of the Use of a
Prohibited Method.
Anti-Doping Organization. A Signatory that is responsible for adopting rules for initiating,
implementing or enforcing any part of the Doping Control process. This includes, for example,
the International Olympic Committee, the International Paralympic Committee, other Major
Event Organizations
that conduct Testing at their Events, WADA, International Federations, and
National Anti-Doping Organizations.
Athlete. Any Person who participates in sport at the international level (as defined by each
International Federation), the national level (as defined by each National Anti-Doping
Organization
, including but not limited to those Persons in its Registered Testing Pool), and any
other competitor in sport who is otherwise subject to the jurisdiction of any Signatory or other
sports organization accepting the Code. All provisions of the Code, including, for example,
Testing, and TUE's must be applied to international and national-level competitors. Some
National Anti-Doping Organizations may elect to test and apply anti-doping rules to
recreational-level or masters competitors who are not current or potential national caliber
competitors. National Anti-Doping Organizations are not required, however, to apply all aspects
of the Code to such Persons. Specific national rules may be established for Doping Control for
non-international-level or non-national-level competitors without being in conflict with the
Code. Thus, a country could elect to test recreational-level competitors but not require TUE's or
whereabouts information. In the same manner, a Major Event Organization holding an Event
only for masters-level competitors could elect to test the competitors but not require advance
TUE or whereabouts information. For purposes of Article 2.8 (Administration or Attempted
Administration) and for purposes of anti-doping information and education, any Person who
participates in sport under the authority of any Signatory, government, or other sports
organization accepting the Code is an Athlete.
[Comment to Athlete: This definition makes it clear that all international and national-caliber
athletes are subject to the anti-doping rules of the Code, with the precise definitions of
international and national level sport to be set forth in the anti-doping rules of the IFs and
National Anti-Doping Organizations, respectively. At the national level, anti-doping rules
adopted pursuant to the Code shall apply, at a minimum, to all persons on national teams and all
persons qualified to compete in any national championship in any sport. That does not mean,
however, that all such Athletes must be included in a National Anti-Doping Organization's

WBPF Anti-Doping Rules
August 2009

Registered Testing Pool. The definition also allows each National Anti-Doping Organization, if it chooses to do so, to expand its anti-doping program beyond national-caliber athletes to competitors at lower levels of competition. Competitors at all levels of competition should receive the benefit of anti-doping information and education.] Athlete Support Personnel. Any coach, trainer, manager, agent, team stWBPFf, official, medical, paramedical personnel, parent or any other Person working with, treating or assisting an Athlete participating in or preparing for sports Competition. Attempt. Purposely engaging in conduct that constitutes a substantial step in a course of conduct planned to culminate in the commission of an anti-doping rule violation. Provided, however, there shall be no anti-doping rule violation based solely on an Attempt to commit a violation if the Person renounces the Attempt prior to it being discovered by a third party not involved in the Attempt. Atypical Finding. A report from a laboratory or other WADA-approved entity which requires further investigation as provided by the International Standard for Laboratories or related Technical Documents prior to the determination of an Adverse Analytical Finding. CAS. The Court of Arbitration for Sport. Code. The World Anti-Doping Code. Competition. A single race, match, game or singular athletic contest. For example, a basketball game or the finals of the Olympic 100-meter race in athletics. For stage races and other athletic contests where prizes are awarded on a daily or other interim basis the distinction between a Competition and an Event will be as provided in the rules of the applicable International Federation. [Please insert here specific rules if applicable] Consequences of Anti-Doping Rule Violations. An Athlete's or other Person's violation of an anti-doping rule may result in one or more of the following: (a) Disqualification means the Athlete's results in a particular Competition or Event are invalidated, with all resulting Consequences including forfeiture of any medals, points and prizes; (b) Ineligibility means the Athlete or other Person is barred for a specified period of time from participating in any Competition or other activity or funding as provided in Article 10.10; and (c) Provisional Suspension means the Athlete or other Person is barred temporarily from participating in any Competition prior to the final decision at a hearing conducted under Article 8 (Right to a Fair Hearing). Disqualification. See Consequences of Anti-Doping Rule Violations, above. Doping Control. All steps and processes from test distribution planning through to ultimate disposition of any appeal including all steps and processes in between such as provision of whereabouts information, Sample collection and handling, laboratory analysis, TUE's, results management and hearings. WBPF Anti-Doping Rules
August 2009

Event. A series of individual Competitions conducted together under one ruling body (e.g., the Olympic Games, FINA World Championships, or Pan American Games). Event Period. The time between the beginning and end of an Event, as established by the ruling body of the Event. In-Competition. Unless provided otherwise in the rules of an International Federation or other relevant Anti-Doping Organization, "In-Competition" means the period commencing twelve hours before a Competition in which the Athlete is scheduled to participate through the end of such Competition and the Sample collection process related to such Competition. Independent Observer Program. A team of observers, under the supervision of WADA, who observe and may provide guidance on the Doping Control process at certain Events and report on their observations. Individual Sport. Any sport that is not a Team Sport. Ineligibility. See Consequences of Anti-Doping Rule Violations above. International Event. An Event where the International Olympic Committee, the International Paralympic Committee, an International Federation, a Major Event Organization, or another international sport organization is the ruling body for the Event or appoints the technical officials for the Event. International-Level Athlete. Athletes designated by one or more International Federations as being within the Registered Testing Pool for an International Federation. International Standard. A standard adopted by WADA in support of the Code. Compliance with an International Standard (as opposed to another alternative standard, practice or procedure) shall be sufficient to conclude that the procedures addressed by the International Standard were performed properly. International Standards shall include any Technical Documents issued pursuant to the International Standard. Major Event Organizations. The continental associations of National Olympic Committees and other international multi-sport organizations that function as the ruling body for any continental, regional or other International Event. Marker. A compound, group of compounds or biological parameter(s) that indicates the Use of a Prohibited Substance or Prohibited Method. Metabolite. Any substance produced by a biotransformation process. Minor. A natural Person who has not reached the age of majority as established by the applicable laws of his or her country of residence. WBPF Anti-Doping Rules
August 2009

National Anti-Doping Organization. The entity(ies) designated by each country as possessing the primary authority and responsibility to adopt and implement anti-doping rules, direct the collection of Samples, the management of test results, and the conduct of hearings, all at the national level. This includes an entity which may be designated by multiple countries to serve as regional Anti-Doping Organization for such countries. If this designation has not been made by the competent public authority(ies), the entity shall be the country's National Olympic Committee or its designee. National Event. A sport Event involving international or national-level Athletes that is not an International Event. National Federation. A national or regional entity which is a member of or is recognized by IF as the entity governing the IF's sport in that nation or region. National Olympic Committee. The organization recognized by the International Olympic Committee. The term National Olympic Committee shall also include the National Sport Confederation in those countries where the National Sport Confederation assumes typical National Olympic Committee responsibilities in the anti-doping area. No Advance Notice. A Doping Control which takes place with no advance warning to the Athlete and where the Athlete is continuously chaperoned from the moment of notification through Sample provision. No Fault or Negligence. The Athlete's establishing that he or she did not know or suspect, and could not reasonably have known or suspected even with the exercise of utmost caution, that he or she had Used or been administered the Prohibited Substance or Prohibited Method. No Significant Fault or Negligence. The Athlete's establishing that his or her fault or negligence, when viewed in the totality of the circumstances and taking into account the criteria for No Fault or Negligence, was not significant in relationship to the anti-doping rule violation. Out-of-Competition. Any Doping Control which is not In-Competition. Participant. Any Athlete or Athlete Support Personnel. Person. A natural Person or an organization or other entity. Possession. The actual, physical Possession, or the constructive Possession (which shall be found only if the person has exclusive control over the Prohibited Substance or Prohibited Method or the premises in which a Prohibited Substance or Prohibited Method exists); provided, however, that if the person does not have exclusive control over the Prohibited Substance or Prohibited Method or the premises in which a Prohibited Substance or Prohibited Method exists, constructive Possession shall only be found if the person knew about the presence of the Prohibited Substance or Prohibited Method and intended to exercise control over it. Provided, however, there shall be no anti-doping rule violation based solely on Possession if, prior to receiving notification of any kind that the Person has committed an anti-doping rule violation, WBPF Anti-Doping Rules
August 2009

the Person has taken concrete action demonstrating that the Person never intended to have Possession and has renounced Possession by explicitly declaring it to an Anti-Doping Organization. Notwithstanding anything to the contrary in this definition, the purchase (including by any electronic or other means) of a Prohibited Substance or Prohibited Method constitutes Possession by the Person who makes the purchase. [Comment: Under this definition, steroids found in an Athlete's car would constitute a violation unless the Athlete establishes that someone else used the car; in that event, the Anti-Doping Organization must establish that, even though the Athlete did not have exclusive control over the car, the Athlete knew about the steroids and intended to have control over the steroids. Similarly, in the example of steroids found in a home medicine cabinet under the joint control of an Athlete and spouse, the Anti-Doping Organization must establish that the Athlete knew the steroids were in the cabinet and that the Athlete intended to exercise control over the steroids.] Prohibited List. The List identifying the Prohibited Substances and Prohibited Methods. Prohibited Method. Any method so described on the Prohibited List. Prohibited Substance. Any substance so described on the Prohibited List. Provisional Hearing. For purposes of Article 7.6, an expedited abbreviated hearing occurring prior to a hearing under Article 8 (Right to a Fair Hearing) that provides the Athlete with notice and an opportunity to be heard in either written or oral form. Provisional Suspension. See Consequences of Anti-Doping Rules Violations above. Publicly Disclose or Publicly Report. To disseminate or distribute information to the general public or persons beyond those persons entitled to earlier notification in accordance with Article 14. Registered Testing Pool. The pool of top level Athletes established separately by each International Federation and National Anti-Doping Organization who are subject to both In-Competition and Out-of-Competition Testing as part of that International Federation's or National Anti-Doping Organization's test distribution plan. Retroactive TUE. As defined in the International Standard for Therapeutic Use Exemptions. Sample or Specimen. Any biological material collected for the purposes of Doping Control. [Comment to Sample or Specimen: It has sometimes been claimed that the collection of blood Samples violates the tenets of certain religious or cultural groups. It has been determined that there is no basis for any such claim.] Signatories. Those entities signing the Code and agreeing to comply with the Code, including the International Olympic Committee, International Federations, International Paralympic WBPF Anti-Doping Rules
August 2009

Committee, National Olympic Committees, National Paralympic Committees, Major Event Organizations, National Anti-Doping Organizations, and WADA. Specified Substances. As defined in Article 4.2.2. Substantial Assistance. For purposes of Article 10.5.3, a Person providing Substantial Assistance must: (1) fully disclose in a signed written statement all information he or she possesses in relation to anti-doping rule violations, and (2) fully cooperate with the investigation and adjudication of any case related to that information, including, for example, presenting testimony at a hearing if requested to do so by an Anti-Doping Organization or hearing panel. Further, the information provided must be credible and must comprise an important part of any case which is initiated or, if no case is initiated, must have provided a sufficient basis on which a case could have been brought. Tampering. Altering for an improper purpose or in an improper way; bringing improper influence to bear; interfering improperly; obstructing, misleading or engaging in any fraudulent conduct to alter results or prevent normal procedures from occurring; or providing fraudulent information to an Anti-Doping Organization. Target Testing. Selection of Athletes for Testing where specific Athletes or groups of Athletes are selected on a non-random basis for Testing at a specified time. Team Sport. A sport in which the substitution of players is permitted during a Competition. Testing. The parts of the Doping Control process involving test distribution planning, Sample collection, Sample handling, and Sample transport to the laboratory. Trafficking. Selling, giving, transporting, sending, delivering or distributing a Prohibited Substance or Prohibited Method (either physically or by any electronic or other means) by an Athlete, Athlete Support Personnel or any other Person subject to the jurisdiction of an Anti-Doping Organization to any third party; provided, however, this definition shall not include the actions of bona fide medical personnel involving a Prohibited Substance used for genuine and legal therapeutic purposes or other acceptable justification, and shall not include actions involving Prohibited Substances which are not prohibited in Out-of-Competition Testing unless the circumstances as a whole demonstrate such Prohibited Substances are not intended for genuine and legal therapeutic purposes. TUE. As defined in Article 2.6.1. TUE Panel. As defined in Article 4.4.4. UNESCO Convention. The International Convention against Doping in Sport adopted by the 33rd session of the UNESCO General Conference on 19 October 2005 including any and all amendments adopted by the States Parties to the Convention and the Conference of Parties to the International Convention against Doping in Sport. WBPF Anti-Doping Rules
August 2009

Use. The utilization, application, ingestion, injection or consumption by any means whatsoever
of any Prohibited Substance or Prohibited Method.
WBPF: World Body Building & Physique Sports Federation
WADA. The World Anti-Doping Agency.
WBPF Anti-Doping Rules
August 2009

APPENDIX 2 - Confirmation

I, as a member of [National Federation] and/or a participant in a [National Federation or WBPF]
authorized or recognized event, hereby declare as follows:
1.
I confirm that I shall comply with and be bound by all of the provisions of the WBPF Anti-Doping Rules, including but not limited to, all amendments to the Anti-Doping Rules and all International Standards as issued by the World Anti-Doping Agency and permanently published on its website. I acknowledge that [National Federations, WBPF and National Anti-Doping Organisations] have jurisdiction to impose sanctions as provided in the WBPF Anti-Doping Rules. I have read and understand the present declaration. Print Name (Last Name, First Name) Signature (or, if a minor, signature of (Day/Month/Year) WBPF Anti-Doping Rules
August 2009.

Source: http://www.wbpf.us/_service/downloadFile.ashx?fileid=be097fdd-723b-4099-a2f5-69a01410c65b

Common cardiac related medications.pdf

Related Medications Dr. Naresh Kumar Whitby Cardiovascular Institute This reference was created by Arjun Kumar using the ‘OXFORD HANDBOOK OF PRACTICAL DRUG THERAPY' The document itself is property of Whitby Cardiovascular Institute © Whitby Cardiovascular Institute 2006 This document has been created to help answer some of the questions

www1.pfizerpro.com

FOR FREQUENT HEARTBURN Tools and information for you and your pharmacy team Nexium® 24HR P H A R M A S S I S T K I T As a pharmacist, you play an important role in helping patients make informed decisions about treatments for frequent heartburn. This Nexium 24HR PharmAssist Kit from Pfizer Consumer Healthcare provides you with information and tools you can use to be better prepared for patient consultations